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Abstract
The primary purpose of this research was to improve the effectiveness of cost
comparison analyses for the 75th Aerospace Medicine Group, Hill Air Force Base, Utah.
Bioenvironmental engineers sought a more robust cost comparison tool, allowing
engineers to quickly determine the viability of proposed occupational health-related
expenditures. To justify the funding of potential projects, engineers must quantify the
expected cost savings. Improved cost comparison analysis enables personnel to better
justify worthy projects or filter out uneconomical solutions.
A secondary purpose of this research was to validate Department of Defense
(DoD) occupational illness cost factors. This research effort focused on cost factors for
illnesses resulting in no lost work time and for illness resulting in hospitalization. The
existing cost factors were developed in 1988, and no continuity or existing methodology
is available to determine how the factors were developed. We modeled direct medical
expenditures related to occupational illness for a specific set of illnesses for active duty
Air Force personnel to validate the “no lost time” factor. Additionally, we attempted to
validate and apportion the hospitalization factor into direct and indirect occupational
illness costs. This new knowledge will allow leaders to plan for and mitigate potential
occupational illness costs.
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MODELING U.S. AIR FORCE OCCUPATIONAL HEALTH COSTS
I. Introduction

Background
“Lack of evidence on cost-effectiveness is likely to be regarded as the same as
activities demonstrated not to be cost-effective” (Miller, Rossiter, & Nuttall, 2002: 477).
The preceding quotation states the overarching problem to improving occupational health
processes. If cost estimating models cannot deliver reliable and defendable results, one
should not expect investments to be made. This holds true in most instances, to include
occupational health.
Convincing leaders to invest scarce resources on support functions is challenging,
and rightly so. In a sense, commanders are fiduciaries to the taxpayers and must
responsibly spend appropriated funds. While safety and occupational health
requirements will likely rank high on any commander’s priority list, such requirements
seldom receive enough attention and justification to warrant funding.
Bioenvironmental engineers (BEEs) are tasked with ensuring occupational health
requirements receive necessary attention. The 75th Aerospace Medicine Squadron,
Bioenvironmental Engineering Flight at Hill Air Force Base, Utah (75 AMDS/SGPB) is a
good example of a real-world operational unit that spends a considerable amount of time
analyzing potential occupational health risks and initiatives for improvements. BEEs
ensure workers are not exposed to dangerous workplace conditions. They advocate for
process improvement or material substitutions that help mitigate potential hazards. While
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BEEs often link tangible benefits such as cost or personnel savings to process changes,
they also must consider the indirect costs associated with their recommendations.
The direct costs associated with the aforementioned initiatives are usually
quantifiable. Direct costs of occupational illnesses include medical bills, insurance
compensation, and other costs directly attributable to an occupational illness. Direct
benefits also include savings of time, money, materials or any combination of the three.
Capturing indirect costs is much more difficult. Occupational illness costs are
synonymous to an iceberg floating in the water. See Figure 1 for an example, modeled
after WSES.biz, 1992. The smaller direct costs, represented by the portion of the iceberg
above the water, are visible and easier to tally. The disproportionately larger indirect
costs, hidden below the water in the proverbial iceberg, have been estimated as high as $6
to $53 for each $1 of direct cost (Bird & Germain, 1996: 8). These indirect costs include
employee turnover, lower morale, lost production, lost time wages, administrative
burden, lost sales, and lost reputation/goodwill (Basu & Wright, 2005).

Figure 1. Total Cost of Illness “Iceberg”
$1 Direct Costs for:
Medical Bills
Insured Costs

$1
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

$6 to $53

$5 to $50 Ledger Costs for:
Building/Tool Damage
Equipment Damage
Legal Expenses
Emergency/Interim Supplies
$1 to $3 Uninsured Costs for:
Investigations
Lost Productivity
Turnover
Lost Wages
Lost Goodwill
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Illnesses are much more complicated to quantify than injuries. To differentiate,
occupational injuries are readily attributable to a specific time, place and cause. Injuries
are a result of “rapid, uncontrolled transfer of energy (chemical, electromagnetic,
electrical, thermal, and mechanical) to an individual resulting in loss” (Slagley, 2008).
Illnesses, on the other hand, are usually the result of repeated exposure to an adverse
physical or chemical factor in the workplace.
The exact dollar figure for indirect illness costs is difficult to quantify for several
reasons. As previously noted, occupational illnesses generally happen as a result of longterm exposure to a hazard. A patient may no longer be employed at the organization
where the exposure occurred when he or she becomes ill. Doctors may not attribute the
illness to an occupation, resulting in an under reporting of occupational illness and the
associated cost. Occupational illnesses are difficult to link to specific causes. Illnesses
could result from a multitude of factors, such as genetic disposition to disease, previous
exposure, certain combinations of exposures, and general health of an individual.
Finally, the severity and duration of illness are major factors in determining indirect
costs. Illnesses lasting longer or causing more pain, suffering, and disability will be more
expensive, simply based on the need for more medicine, longer hospitalizations, and
higher percentages of worker’s compensation.
Problem Statement
Bioenvironmental engineers seek a robust, transparent, and defendable tool to
capture and articulate potential cost savings associated with occupational health
expenditures, convincing decision makers that investing scarce resources in occupational
health matters can be a highly effective use of funds. Engineers can accomplish this task
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by changing the way decision makers think in terms of cost-effectiveness. While initial
capital costs may be much less for one alternative, the “cheaper” option with lower startup costs may end up being the more expensive course of action in the long run. We will
demonstrate how the entire life cycle costs must be considered before determining which
alternative is best. The engineers are currently experiencing some difficulty accurately
quantifying costs of potential occupational health projects.
The existing methodology compares the cost of a new process, such as new
equipment, training, or manpower with the expected benefits, such as reduced
materials/time/personnel. However, the existing methodology ignores the time value of
money because engineers compare the initial cost of a new process with the cost of the
current process. Some new processes may initially require a capital investment, making
the project seem more expensive than it really is. The existing methodology does not
allow engineers to accurately compare alternatives using concepts such as equivalent
annual cost, breakeven analysis, or sensitivity analysis.
In addition to making the cost comparisons more accurate, bioenvironmental
engineers must be able to determine the total cost of occupational illness. Total cost is
determined by combining direct and indirect costs. Cost analysts need to apportion the
DoD hospitalization cost factor into direct and indirect cost components. If analysts are
able to apportion the costs, follow-on research and modeling efforts may allow engineers
to use this information to further improve project justifications.
Research Objectives
Research Questions.
What is the most effective cost comparison methodology to use?
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Is the DoD cost factor for occupational illness resulting in no lost time a reliable
estimate for medical costs?
Can the DoD total cost factor for occupational illness resulting in hospitalization
be separated into direct and indirect costs?
Hypothesis.
1. Using equivalent annual cost methodology when performing cost comparison
analyses may result in choosing alternatives which were previously believed
to be too expensive.
2. DoD cost factor for occupational illness resulting in no lost time is reliable.
3. DoD cost factor for occupational illness resulting in hospitalization is reliable.
Research Focus
The initial area of research focuses on determining the most effective cost
comparison tool for situations typically encountered by bioenvironmental engineers from
the 75th Aerospace Medicine Squadron at Hill Air Force Base, Utah. The end product
will include a software-based user interface, such as a Microsoft Excel® spreadsheet, to
facilitate analyses.
Additionally, research efforts will seek to validate existing DoD occupational
illness cost factors. The DoD cost factor for no lost time estimates the direct medical
expenses resulting from ambulatory visits for occupational illnesses. The cost factor for
hospitalization supposedly estimates total cost, to include both direct and indirect
occupational illness costs for hospitalization of occupational illnesses. According to DoD
Instruction 6055.07, Accident Investigation, Reporting, and Record Keeping, the total
costs include pay while away from work, medical treatment, hospitalization, dependent
survival, training costs, burial, compensation, and disability retirement (DoD: 2008). We
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theorize the total costs are extremely elusive to capture, based on research of existing
attempts at estimating indirect cost. We will use direct medical costs for Active Duty Air
Force personnel from FY1999 to FY2008 for a specific set of 74 illnesses to model direct
and indirect cost factors. We will then compare our new factors with DoD’s attempt in
1988 to estimate illness costs.
Assumptions
Several assumptions must be made to facilitate the research efforts. To start, the
author will develop a cost comparison methodology generic enough to cover foreseeable
situations at an Air Logistics Center, such as Hill Air Force Base. The methodology will
allow comparison of alternatives with equal project lives and allow users to vary inputs
and see the resulting impact via a graphical display.
The methodology will also incorporate time value of money. Time value of
money is normally associated with commercial endeavors when the interest rate, or cost
of borrowing capital, and the discount rate, or expected return on capital, greatly affect
the decision outcome. A dollar spent today has a different value than a dollar spent 10
years from now. While Air Force expenditures are not normally affected by interest rates
from a “business” point of view, decision makers should consider discount rates and time
value of money because some alternatives may require a significant outlay of capital in
the short term. An appropriate discount rate will determine if the capital-intensive
alternative is worth the risk.
When considering a discount rate in the final model, there are limitations of
accuracy in estimating these rates. The Office of Management and Budget (OMB)
recommends using a 7% internal rate of return (OMB Circular A-94). A single discount
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rate may simplify calculations for the end user instead of determining a variable rate
based on the length of project. We do not feel setting the discount rate at 7%
compromises the final model. If a sensitivity analysis of several alternatives results in
changing in a decision based on the discount rate fluctuation, we feel other tangible
factors will take precedence in the decision process.
Implications
The cost comparison tool could have potential service-wide implications. Many
decisions makers throughout the Air Force, whether they are bioenvironmental engineers,
civil engineers, logisticians, or front-line managers, may not have the time or tools
necessary to accurately compare alternatives when allocating budgets. The end product
of this research effort will allow decision makers to have more accurate information.
With more accurate information, we anticipate better decisions, ultimately resulting in
more effective use of taxpayer dollars.
A new understanding of how to reduce medical costs may increase occupational
health expenditures. As a result, occupational health expenditures may lead to safer
working environments through reduced occurrences of occupational illness. According
to the Air Force Operational Risk Management (ORM) website, “ORM is a decisionmaking process to systematically evaluate possible courses of action, identify risks and
benefits, and determine the best course of action for any given situation” (ORM
University, 2008). Decision makers could lower overall costs and improve ORM,
creating a win-win situation for everyone.
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Preview
Discussion will begin with existing literature on the topic of occupational illness,
as well as attempts to capture costs through various methods. The author will develop a
cost comparison tool to meet the customers’ needs, allowing comparison of multiple
options across a range of user input criteria. The author will then develop a regression
model to validate DoD cost factors, based on the amount of direct medical costs. Finally,
the author will discuss the applicability for service-wide use, as well as submit
recommendations to improve analyzing occupational illness costs in the future.
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II. Literature Review
Most pertinent literature regarding occupational illness modeling stems from
ground-breaking efforts by Dr. Paul Leigh. His team performed the most complete effort
to date of estimating direct and indirect costs. Additionally, Dr. Katharyn Grant
published a cost/benefit analysis handbook targeted to Environmental, Safety and
Occupational Health (ESOH) personnel. Dr. Leigh’s and Dr. Grant’s efforts form the
backbone of our research efforts. Follow-on efforts by other researchers provide
refinement and deeper discussion of the challenges of modeling occupational illness
costs.
Historical Perspective
Occupational illness prevention has long been recognized as a critical component
of creating a safe and healthy workplace. In the late 1960s, President Richard Nixon
pointed out the need for increased emphasis on workplace health (Burk & Moeller, 1975:
2). In a message to Congress, President Nixon compared the adequacy of federal safety
and health programs to private businesses. Apparently, federal program administrators
were not keeping up with the advances in technology and manufacturing. As a result of
proposed standards, Congress created the Occupational Safety and Health Act of 1970
(Ibid: 3). However, the act specifically excluded federal agencies by defining an
employer as “…a person engaged in a business affecting commerce…” (Ibid). Upon
further refinement of OSHA directives, Air Force leaders created Air Force Occupational
Safety and Health (AFOSH) equivalent regulations. In fact, the verbiage of the Air Force
regulations called for safety and health standards equal to or better than OSHA standards.
AFOSH programs have since evolved under several organizations, such as Air Force
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ESOH, Air Force Institute of Occupational Health (AFIOH), and finally the U.S. Air
Force School of Aerospace Medicine, located at Brooks City-Base, Texas.
The Air Force definition of occupational illness is “any abnormal condition or
disorder, other than an occupational injury, caused by exposure to environmental factors
related to employment” (Grayson, 1990: 2). The Occupational Safety & Health
Administration (OSHA) defines occupational illness as a physiological harm or loss of
capacity produced by systematic infection; continued or repeated stress or strain;
exposure to toxins, poisons, fumes, etc.; or other continued and repeated exposures to
conditions of the work environment over a period of time. For practical purposes, an
occupational illness or disease is any reported condition not meeting the definition of
traumatic injury (www.osha.gov). To properly differentiate between injuries and
illnesses, consider that injuries are a result of an instantaneous event whereas illnesses are
usually a result from repeated exposure over time.
Cost/Benefit Analysis Methods
In 2001, Dr. Katharyn Grant created a technical guide to assist ESOH workers
with creating economic or cost-benefit analyses. Engineers could then use the analyses to
enhance recommendations for ESOH solutions at Air Force installations (Grant, 2002: 1).
Dr. Grant noted that cost has always been a significant factor when evaluating workplace
changes. She highlighted the importance for ESOH professionals to fully understand
costs associated with their recommendations. Decision makers usually understand
benefits expressed in financial terms. Dr. Grant’s report provides the tools necessary to
express costs and benefits in a manner in which decision makers should readily
understand (Ibid).
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Cost/benefit analyses generally follow a common path of evaluation steps (Ibid).
The basic plan of action for most economic analyses is:
•

Define project goal or desired outcome

•

Identify potential alternatives

•

State assumptions

•

Determine costs

•

Detemine benefits

•

Compare costs/benefits for alternatives

•

Perform sensitivity analysis

•

Select alternative with most advantageous mix of costs/benefits

Properly comparing costs and benefits is perhaps the most challenging technical aspect of
performing an economic analysis. Three methods were compared: net present value,
payback method, and return on investment. Those methods will be discussed and
compared in the following paragraphs.
Net present value (NPV) provides one value of all costs and benefits across the
life of a project. Future costs and benefits are discounted back at an appropriate rate to
provide an accurate comparison of expenditures or benefits occurring at different times.
See Chapter 3, Methodology, for further explanation of discounting. The NPV formula
is:
NPV = FV (1 / 1 + r)t – IC

(1)

where NPV is net present value, FV is future value of benefits, r is the discount rate, t is
the number of time periods the cost or benefit occurs, and IC is the initial capital expense
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of the project (Ibid: 10). ESOH professionals may compare the NPV for a number of
options.
Any NPV above zero means the benefits outweigh the costs. For example,
consider making a choice between Option A and Option B. Option A requires an initial
capital expense of $100 but returns a $200 benefit in 3 years. Option B also costs $100
upfront but returns a $50 benefit in 3 years. Using Equation 1 with a 7% value for r, we
see that Option A provides a NPV of $63.26. Option B provides a NPV of -$59.19.
Option A is better than Option B because Option A has a positive value. Option B costs
more money than it provides over the life of the project. From a strictly financial
viewpoint, the alternative with the highest NPV will normally be the best choice.
Instead of comparing the NPV of alternatives, decision makers may want to know
how quickly their “investment” will pay for itself through reduced costs. Such an
analysis is known as the payback method. The payback method formula is:
PB = C / S

(2)

where PB is the payback period (months, years, et cetera), C is the initial cost, and S is
the recurring benefit or savings. If the payback period is negative, the alternative costs
more than it saves (Ibid: 12). This method of economic analysis is flawed for several
reasons. First, the method does not consider any cost or benefits beyond the payback.
Second, while some methods of payback incorporate discounting or time value of money,
Dr. Grant’s simplified version shown in Equation 2 does not. Finally, the benefits must
be fairly consistent for this equation to work properly. For example, if the initial cost was
$100 and the recurring savings per period was $50, we calculate a payback period of 2
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periods. However, based on these inherent flaws of this methodology, the payback
method will not be considered as a viable option.
Finally, leaders may want to know the return on their investment. Return on
investment (ROI) “represents the percentage of the costs associated with implementing a
project that are recovered as savings over a set period of time” (Ibid). The formula for
ROI is:
ROI = (S / C) * 100%

(3)

where ROI is return on investment, S is the annual benefit or savings, and C is the initial
cost. The ROI method is useful in showing what percentage of the initial cost is
recovered for each time period. This method may be useful as a secondary consideration.
However, ROI does not convey the magnitude of cost or benefits. For example, a project
with annual savings of $5,000 and initial cost $100,000 will have the same 5% ROI as a
project with annual savings of $100 and initial cost of $2,000. Commanders are often
constrained by a one-year budget cycle for specific appropriations. The dollar value of
costs and benefits is often a huge limiting factor, and ROI does not convey this
information directly.
Occupational Illness Modeling
Perhaps the most relevant literature regarding parametric estimation of indirect
costs appears in Occupational Injury and Illness in the United States: Estimates of Costs,
Morbidity, and Mortality. Dr. J. Paul Leigh, et al, provided an early attempt at
quantification of direct and indirect injury and illness costs in the United States. Indirect
illnesses include lost earnings, lost home production, and lost fringe benefits (Leigh,
Markowitz, Fahs, Shin, & Landrigan, 1997: 1557). The authors tied the occurrence of

13

certain illnesses in the United States to the probability of the illness occurring due to
occupational conditions.
The authors provided confidence intervals of illness occurrence along with point
estimates. It is important to distinguish between the two now. Point estimates are
convenient, allowing the end user to have a specific number for further estimates and
calculations. However, the confidence interval approach provides a more realistic,
accurate range of possible values. This is especially true when using the ranges to
provide potential future costs. For example, it cannot be said with much fidelity that 8%
of all cardiovascular disease cases in the next five years are work-related. However,
based on documented research, researchers can estimate that 6% to 10% of
cardiovascular disease cases may be work-related (Leigh J. P., Markowitz, Fahs, &
Landrigan, 2000: 60). Uncertainty may hamper the acceptance of cost models. It is
critical for the cost analyst to communicate the meaning and importance of confidence
intervals when delivering cost estimates to the decision makers. Even so, Dr. Leigh also
used point estimates calculations in order to streamline estimation processes. Dr. Leigh
assumes a normal distribution for the attributable factors, and we will assume likewise.
Some illnesses are mostly attributable to a particular job, such as mesothelioma
and pneumoconiosis (Ibid: 66). Other illnesses occur “naturally” and through exposure
to catalysts in and out of the workplace, such as many forms of cancer (Leigh J. P.,
Markowitz, Fahs, Shin, & Landrigan, 1997: 1559). The authors applied an attributable
risk proportion model for illnesses not 100% attributable to work. The model was
created using results from numerous existing medical studies relating specific diseases to
what proportion resulted from work-related exposures. Other studies acknowledge the
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increased risk of cancer in some occupations without clearly identifying the specific
causes. For example, farmers may have higher rates of lymphoma and fire fighters may
have higher rates of brain cancer (Ibid). Also, smoking warrants special consideration.
Smoking is a personal choice and should not be included as a workplace toxin exposure.
Conversely, the effects of second-hand smoke should be included for certain occupations
where workers are constantly exposed, such as bars and some restaurants.
The cost model developed by Dr. Leigh, et al, uses present value as shown below:
PVDeath = Σ Py,s,n * (Ms,n + Hs,n + Fs,n) * LFPRs,n * (1+g)n-y/(1+r)n-y

(4)

*Note: Summation is from y = n to 75, representing a range of possible working years.
Above, PVDeath is the present discounted value of loss from illness; Py,s,n is the probability
a person of age n, sex s will survive to age y; Ms,n is the mean annual earnings of a person
of sex s and age n; Hs,n is the value of household production of a person of sex s and age
n; Fs,n is the fringe benefits, again based on sex s and age n; LFPR is the labor force
participation rate (0.0 to 1.0); g is the increase in labor productivity, assumed by the
researchers to be 1%; and r is the real discount rate, assumed to be 4% (Ibid: 1561).
Mean annual earnings includes direct salary. Household production includes the value of
household services such as lawn care, general repair, cooking, cleaning, et cetera.
Examples of fringe benefits include loss of vacation time and loss of employer/employee
contribution to retirement accounts. The household production and fringe benefits, as
well as the mean salary based on demographic data, may oversimplify the true value of
loss from illness or injuries. However, to date, it represents the best attempt at capturing
these elusive costs and modeling the estimates for further research.

15

Based on the number of reported illnesses and the estimated portion of those
illnesses occuring due to occupational exposure, the authors determined there were
approximately 817,000 to 907,000 new occupational illnesses in the United States in
1992. As shown in Table 1, the task of estimating the number of occupational illnesses is
very challenging. The numbers of occupational illnesses are not readily tracked by a
central database. Different databases track different sectors of the workforce, and the
possibility to miss counting illnesses or double-counting illnesses is ever present. Table 1
provides an excellent snapshot of how daunting a task it is to calculate the number of
illnesses occuring in this country based on occupational exposure.
Table 1 also provides good rationale to implement the recommendations included
in Chapter 5. Concise, purposeful, accurate databases would negate the ambiguous
ranges of illness and injury occurring in the United States. Without a firm number of
cases to start with, one cannot hope to accurately estimate total costs. We are
immediately faced with much uncertainty, which will only increase as attributable factor
ranges are added to the estimation.
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Table 1. Number of Illnesses, US (1992)
(Reproduced with permission from J.P. Leigh et al, 1997)
Estimated
Attributable
Illness/Source of Data
Number of New
Cases in US
Cancer
1,113,100

Percentage
Attributable
to
Occupation
6% - 10%

Estimated Number of Occupational
Illnesses
66,790 - 111,130

Coronary heart
disease

730,000

5% - 10%

36,500 - 73,000

Cerebrovascular
disease

101,00 - 144,000

5% - 10%

5,050 - 14,400

1,500,000

10%

150,000

Chronic obstructive
pulmonary disease
Subtotal

258,340 - 348,710

Bureau of Labor
Statistics Annual
Survey

457,400

National Institute of
Occupational Safety
and Health

14,250

Public Sector
Employees

92,010

Total*

817,015 - 907,385
* Approximately 5,000 cases removed to avoid estimation overlap

The authors used a median value of 858,165 occupational illnesses for further
calculations. Using Equation 4, the direct cost of occupational illness for this time period
was 16.07 billion dollars and the indirect cost was 9.47 billion dollars, as shown in Table
2. To summarize, the authors calculated each dollar of direct costs results in 59 cents of
indirect costs (Ibid: 1562). If only $1 out of $1.59 is being captured, this equates to
approximately 37% of the total cost of occupational illness not being captured. This is in
stark contrast to previous estimates of $6 to $53 of indirect costs for each $1 of direct
costs. The extreme difference may be due to other indirect cost factors not captured in
the Leigh et al model. Or, it may mean earlier estimates were greatly overstated.

17

Table 2. Number and Costs of Illnesses, US (1992)
(Reproduced with permission from J.P. Leigh et al, 1997)
Number

Direct Cost

Indirect Cost

Total

Deaths

60,293

$10.70B

$9.00B

$19.70B

Morbidity

858,165

$5.37B

$0.47B

$5.84B

$16.07B

$9.47B

$25.54B

Totals

In Dr. Leigh’s sensitivity analysis, he notes that he did not adjust discount rates or
growth rates in the present value model. His team found various discount rates did not
greatly alter the findings. Significant cost variation depended on the numbers and types
of illnesses instead of discount/growth rate changes.
The indirect costs may be underestimated due to the exclusion of pain and
suffering. Additionally, the medical cost data excluded California and New York due to
the disproportionately high cost of healthcare in these two states. Finally, the estimates
ignored the value of home care provided by the family, effects of disabled or absent
parents, and wage losses attributed to disabled persons employed in relatively less
lucrative jobs (Ibid: 1565).
The article provides an excellent framework for this research effort. The authors
provide ample explanation as to why cost estimates for indirect costs had such a large
range. Unless illnesses are attributable to workplace exposure, the cost of occupational
illness cannot be accurately estimated. To further complicate matters, most illnesses do
not surface until many years after exposure, making it more difficult to tie back to a
particular workplace.
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Economic Value of Occupational Health Services
Miller, Rossiter, and Nuttall attempted to determine an economic value of
occupational health services in a workplace (Miller, Rossiter, & Nuttall, 2002: 477).
While the study was based in the United Kingdom, the external validity of the study
allows analysts to make several direct comparisons. To start, the cost of sick workers is
easy to determine. The authors show the total cost of sickness absence led to 12 billion
British Pounds, simply based on the average lost working days per year and the average
cost per worker per day. While such generalizations may not be very accurate in the
aggregate, one cannot overlook the impact occupational health services may have in
reducing these costs (Ibid: 478).
There is a major problem with measuring the impact of occupational health
investments. The impact is the absence of an occupational illness or injury. Counting the
number of times something does not happen is a challenge. Developing a causal
relationship between an illness not occurring and the expenditures made on occupational
health may be impossible. Measuring a reduction in illnesses may be more appropriate.
But, other causes may exist. For instance, a new commander can redirect the corporate
culture, focusing more on process improvement, safety, and proficiency. Any one of
these factors, in addition to increased morale, could lead to a reduction in illness.
Controlling for every alternate explanation is nearly impossible, especially when
organizational leaders want assurance they are spending money on effective programs.
The first model compared the direct cost of administering an occupational health
service within an organization to the expected benefits. If the benefits exceeded the
costs, the program was justifiable. Such benefits included increased health and morale,
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increased performance and productivity, reduced medical/legal costs, enhanced
workplace safety, and reduced sickness absence (Ibid: 479). A few drawbacks
immediately come to mind. It seems only three of the five broad categories are
quantifiable. While absences, productivity or medical costs can be measured, health,
morale, and workplace safety are not as easy to quantify. Even so, this simple break-even
analysis has merit and may be an appropriate area of future research.
Next, the authors attempted to give a valuation to occupational health services by
surveying 38 key decision makers. The decision makers were asked to give a
hypothetical monetary estimation, comparable to an insurance premium making an
occupational health service desirable. The authors calculated the difference between the
hypothetical estimate and the actual premium to determine the “net value added” (Ibid:
480). This method evaluates a manager’s perception of the value of a service,
introducing a fair amount of subjectivity into the process.
Finally, the authors employ an empirical approach with primary data collection.
Three categories of outcomes of occupational health services were developed. The first
category is unobservable outcomes, such as reducing risk and increasing safety
awareness. The second category is clearly observable outcomes, such as sick days, health
costs, and frequency of illnesses. The third category is outcomes which must be
“estimated by proxy, using other observable data” (Ibid: 481). The quality of life of
employees is a major element in the authors’ empirical approach to modeling costs.
However, the authors do not move beyond the concept of empirical modeling. They limit
discussion to developing some type of cost per quality-adjusted work day factor without
showing an actual model or empirical results.
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Managers may not fully understand the costs or benefits of occupational health
services. From a purely business standpoint, key decision makers may only need to know
the benefits outweigh the costs. If this is the case, analysts would only need to quantify
occupational health benefits to the break-even point. One must consider the costs of
long-term solutions, as well. There is much uncertainty involved when quantifying
benefits to an employee after he or she has been retired for 10 years. This approach may
lead to minimizing costs or overstating benefits to reach favorable conclusions. Clearly,
a more empirical approach is desired.
Social/Economic Impacts of Workplace Illnesses
Occupational illnesses have many impacts. Workers, employers, families, and
society as a whole are all impacted. There are monetary costs and social costs. It is
troubling that only a fraction of the total “bill” is understood. Some estimates suggest for
every week a worker is off the job due to an occupational illness or injury, he or she loses
an average of ten thousand dollars in earnings (Boden, Biddle, & Spieler, 2001: 399).
Employees lose direct wages when they become sick or injured. Additionally, they may
lose their place in seniority or promotions and may have to accept other jobs with lower
pay to accommodate any limitations imposed by the illness or injury. This figure, of
course, depends on the type, severity, and duration of illness, as well as the employee’s
socio-economic status before, during, and after the illness. The authors point to research
showing ill workers are unable to fulfill social, work, or family roles. The resulting
“diminished earnings, long-term physical limitations, depression, fear, and anger” further
increase their psychological and economic suffering (Ibid).
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In the past, the only costs most employers considered stemmed from worker’s
compensation. However, worker’s compensation is just one of many other factors. As
noted earlier, indirect costs include such things as training and hiring replacement
workers, lost productivity, downtime, redundancy as a risk management strategy, and
decreased morale/public relations. To make matters even more complicated, the
aforementioned costs will vary greatly depending on the occupation,
frequency/severity/duration of illness, and a host of other demographics. The expansive
list of variables presents a considerable challenge to developing an all-encompassing
indirect occupational illness cost model. The poor quality and quantity of available data
does not help the issue (Ibid: 401).
Estimating Indirect Costs of Illness: Assessing Forgone Earnings
One of the biggest indirect costs of occupational illness is the loss of earnings
experienced by an employee. Calculating these forgone earnings would capture a
significant portion of the indirect cost “iceberg.” However, there are serious issues with
relying solely on forgone earnings calculations. As Dr. Glied points out, “while the
forgone earnings approach is certainly less complicated than measuring willingness to
pay for increased risk, it will not provide appropriate or consistent estimates unless it is
used with great care” (Glied, 1996: 1728).
The forgone earnings approach methodology allows the analyst to approximate
the wages an employee would have likely earned had he or she not become ill or injured.
The average earnings of a cross-sectional pool of people sharing similar demographics
are discounted back to an established base year. The forgone earnings equation is as
follows:

22

Forgone earnings = ∑ E n+i, m

(5)

where E is the estimated earnings for a person age n in year m. The summation is from 1
to i, based on the necessary span of time. The author uses a generic time period of 15
years in the study. However, a 20-year old individual will likely require longer analysis
while a 60-year old individual may require less. In the study, the author shows a 20-year
old Caucasian male would likely earn $161,157 in the 15 years spanning from 1973 to
1988. The dollar figure is set to a base year of 1980, discounted at 4% per anum. The
actual earnings for this group and time period were $128,723. This particular example
shows a resulting error of 20.1%, one of the worst error rates when comparing the
author’s estimations to actual earnings for particular groups and times (Ibid: 1725-1726).
There are some marked problems associated relying solely on the forgone
earnings approach. First, this approach is only useful if calculating earnings forgone due
to death. Otherwise, it would be difficult to determine the length of time an individual
will remain out of work due to the injury or illness. Even so, using the average life
expectancy based on the age of the individual at the time of death introduces its own
source of error. Also, there is an enormous amount of variation in the estimates, as
shown in the above paragraph. Business cycles, advances in technology, labor market
conditions, and population changes all impact earnings estimates. Finally, the younger
the employee is at the time of death/injury/illness, the more divergence present in the real
earnings growth. Sensitivity analyses may help control for some of these sources of
error. The extreme variance of forgone earnings estimates and substantial impact of
external factors (business cycles, labor markets, et cetera) will not provide decision
makers the clean, accurate, and convenient indirect cost estimate they may desire.
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Magnitude of Mortality
Dr. J.P. Leigh et al developed the first relatively transparent occupational illness
cost model by estimating the portion of illnesses attributable to occupational exposure.
Dr. Kyle Steenland et al used similar attributable factors to specifically determine the
magnitude of deaths from a specific set of diseases. By analyzing causes of death in the
U.S. in 1997, Steenland et al gathered International Statistical Classification of Diseases
and Related Health Problems codes, 9th Edition (ICD-9). The ICD-9 codes are used by
medical professionals to describe illnesses and injuries, making computer data entry and
analysis more efficient. Each ICD-9 code is directly related to a particular illness or
injury. The authors calculated attributable factors for a specific set of illnesses and
multiplied the factors by the total number of the illnesses reported in 1997. The
following is a list of illnesses reviewed in the document: pneumoconiosis, occupational
asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, and specific
cancers. The attributable factor equation is as follows:
Attributable Factor =

P (E) (RR – 1)
1 + P (E) (RR – 1)

(6)

Where P (E) is the proportion of the general population exposed to a particular agent, and
RR is the relative risk of death or disease for someone exposed as compared to someone
not exposed (Steenland, Burnett, Lalich, Ward, & Hurrell, 2003: 463).
While the attributable factors were used for most diseases, some diseases
warranted special attention. For instance, it can be argued pneumoconiosis is 100%
attributable to occupational exposure (Ibid: 464). The attributable factor for COPD was
taken from “community-based studies of the general population rather than from
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workplace- and industry-specific studies” (Ibid: 465). Other case-specific adaptations
were made in the study, such as eliminating causes of death with less than 50 deaths in
the year. Also, occupational noise, shift work, and second-hand tobacco smoke were not
considered as a cause of death themselves, but as compounding factors to other causes of
death such as coronary heart disease. Table 3 shows Steenland’s results for job-related
deaths caused by illness in 1997. This table once again points out the complexity of
quantifying victims of occupational illness. The wide range of deaths reported by
Steenland in Table 3 and the range reported by Leigh in Table 1 lend some credibility to
the wide variance in indirect costs initially reported by Basu and Wright in Figure 1.

Table 3. Estimated Number of Job-Related Deaths Due to
Illness, US (1997)
(Reproduced with permission from Dr. Kyle Steenland et al, 2003)
Cause

Number of Occupational Deaths

Selected Respiratory Diseases

6,805 - 26,686

Selected Cancers

12,086 - 26,244

Coronary Heart Disease

6,037 - 18,253

Selected Renal Diseases

328 - 580

Other Occupational Diseases

50 - 350

Total

25,910 - 72,121

The authors acknowledge the results were “broadly consistent” with other
estimation efforts such as Dr. Leigh’s (Ibid: 474). However, several sources of potential
underestimation and overestimation were noted. The results could be underestimated due
to the limited set of diseases captured in the study. Many diseases are believed to be
caused by occupational factors but were excluded unless scientific research established a
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direct relationship. Also, diseases were excluded if less than 50 deaths were reported.
Overestimation could take place when developing confounding attributable factors, such
as how or if smoking increases the risk for coronary heart disease. Also, estimating a
composite attributable factor for several diseases or risk factors could lead to
overestimation. The mortality estimation results place occupational disease-related
deaths as the 8th leading cause of death in 1997, after diabetes but before suicide. To add
some perspective, deaths from occupational-related diseases are estimated to be greater
than yearly motor vehicle deaths (Ibid: 477).
As the aforementioned research efforts clearly demonstrate, modeling
occupational illness costs is difficult. There is uncertainty in the exact number of
illnesses as well as the percent caused by occupational exposure. After considering the
DoD’s approach to estimating illness costs, we will build upon the tools and techniques
developed in previous research efforts by developing a methodology to model
occupational illness costs for Air Force personnel.
Accident Investigation, Reporting, and Record Keeping
The Department of Defense, in compliance with OSHA guidelines, has
established its own accident/illness investigation, reporting and record keeping. DoD
Instruction 6055.07, updated in April 2008, outlines the processes for the aforementioned
activities. These processes are specifically developed to comply with federal job safety
mandates, such as Executive Order 12196 and 29 Code of Federal Regulations (CFR)
1960 (Defense, 2008: 2).
DoD policy authorizes the implementation of workplace programs for two
purposes:
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1. “Investigate, report, and keep related records on accidental death, injury,
occupational illness, and property damage for DoD accidents covered by this
Instruction and/or specific statutory authority (Ibid).”
2. “Prescribe and enforce regulations directly related to investigation, reporting,
and keeping records on accidental death, injury, occupational illness, and property
damage (Ibid.)”
Such programs may help leaders utilize historical data as appropriate when developing or
acquiring new acquisition systems. The data may also be used to estimate future costs
based on past experience.
To aid in estimating future costs, DoD personnel developed cost estimation
factors in 1988. The factors estimate costs when personnel succumb to illness or injury
on the job. We attempted to ascertain the methodology behind the DoD cost factors.
Unfortunately, the methodology is not available, either due to lack of continuity or
unfamiliarity with illness estimating techniques. As stated in the document, “They [cost
factors] were developed in 1988 and have not been updated so that analysts can make
generalized comparisons against historical data (Defense, 2008: 35).”
Fortunately, we are able to properly analyze historical Air Force medical cost data
for the past 10 years in order to update or validate the outdated cost factors for the DoD.
To summarize Table E7.T1, Cost Standards, enlisted and commissioned personnel cost
$120 per day for illness resulting in no lost time. We assume no lost time simply means
an employee falls ill at work, seeks care at a treatment facility, then returns to work on
the same day or at latest the following day. For illnesses resulting in hospitalization,
enlisted and commissioned personnel cost $466 per day. We assume days of
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hospitalization equate to bed days as reported by medical cost databases. Again, these
figures are based in 1988 dollars.
The DoD Instruction adequately outlines responsibilities, processes, and other
administrative issues. However, there is no mention or reference as to how the cost
factors were developed. We seek to validate these factors or recommend updated factors
for more accurate illness cost estimating for the DoD.
Now that we have examined existing relevant research, we can develop a
methodology that will allow us to answer our research questions. First, we will develop a
suitable cost/benefit analysis tool. Then, we will develop a methodology to analyze the
DoD cost factors.
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III. Methodology
Cost Comparison Analysis
Net Present Value.
To begin discussion of cost/benefit analysis methods, some basic assumptions
must be established. Many economic analysis methods incorporate a discount rate in the
calculations. Discount rates determine the required return rate of investing capital. The
basic premise of including a discount rate is to account for the time value of money.
Simply put, it is cheaper to spend money later versus now. It is better to earn money now
versus later. We will use discount rates to quantify the potential costs and benefits of
investing government appropriations.
Government appropriations are much different than corporate funding because
they are not impacted as much in terms of traditional interest rates for borrowing or
lending. When a commander needs capital to build a new road, she either uses available
funds or asks higher headquarters for more budget authority. To simplify discussion,
there are no bonds to issue, stocks to sell, or loans to take. Operations and Maintenance
(O&M) funds are generally available for only one year. However, interest rates can enter
the picture when the time frame exceeds one year.
According to Air Force Manual 65-506, Economic Analysis, analysts should use
an interest rate equal to a 3, 5, 7, 10 or 30 year Treasury bill/bond when evaluating the
net present value of a potential project. It is important to distinguish between interest
and discount rates. Interest rates are the cost of borrowing money and discount rates are
the expected return on the capital investment. The two concepts are similar and are even
used interchangeably in some texts. The timeline of the project will dictate the applicable
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Treasury rate to use (SAF/FMC, 2004: 10). The Treasury rates are essentially the
government’s cost of borrowing money. As such, the rates serve as a proxy for
discounting government appropriations to determine a net present value.
In contrast, the OMB states a 7% rate shall be used (whitehouse.gov). We feel
this set 7% rate is simple, effective, and robust enough for the types of cost/benefit
analyses to be conducted by bioenvironmental engineers. The OMB rate removes one
more variable from the equation, simplifying the process even more. Further, Dr. Leigh’s
previously mentioned research showed the interest rate or discount rate was not a
significant factor in the sensitivity analysis.
Net present value is a method of determining a value of an alternative at a given
point in time. All costs and benefits are expressed in terms of a common time. Future
costs and benefits are discounted back at an appropriate interest rate. As noted earlier,
the Air Force Manual 65-506 contains methodology for discounting by using Treasury
Bill rates. To demonstrate net present value, consider the following example.

Time 0

$200

$100

Time 1

The above timeline represents an initial cost of $100 at Time 0, noted by the downward
pointing arrow, and a future expected benefit of $200 at Time 1, noted by the upward
pointing arrow. Assume a nominal interest rate of 7%, as recommended by the OMB.
Whether or not spending $100 now to receive $200 in the future depends on two factors.
The first factor is time, specifically the length of time between an expenditure and the
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receipt of any future benefit. The second factor is the interest rate. Recall from Equation
1 the formula for net present value: NPV = FV (1 / 1 + r)t - IC. The present value of the
$200, discounted back one period at 7% equals $186.92. The net present value is simply
the present value of future benefits minus the present value of current and future costs. In
this example, simply subtract $100 from $186.92 to get a net present value of $86.92.
This value represents the value of benefits above and beyond any costs incurred. As long
as the net present value is greater than zero, it makes financial sense to make the
investment.
Equivalent Annual Cost.
Net present value is a powerful tool for determining when to make an investment.
However, it may not be the best analysis method when evaluating government, or publicsector, projects. Public-sector economic problems are often more difficult than privatesector economic problems for several reasons including (Eschenbach, 2003: 363):
•

Benefits are difficult to determine/quantify in terms of money

•

Long time horizons increase risk

•

Policy/bureaucracy challenges

•

Interest rate selection is difficult

To further complicate matters, the short annual cycle of O&M funding hampers decision
makers from fully considering future costs and benefits of a project. Most decision
makers tend to focus on the annual impact to the overall budget. The Equivalent Annual
Cost (EAC) is the solution to this problem.
The EAC is a uniform dollar amount at the end of each period, equal to the
overall costs for a project (Ibid: 139). The EAC will allow comparison of equivalent
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annual costs between two alternatives, giving commanders an “apples to apples”
comparison of the long-term impact on a budget. Using some simple equations, the EAC
can be calculated based on a known present value or cost. The formula for computing an
EAC based on a present value is:
EAC = (PV*((i*(1 + i)N)/((1 + i)N – 1))) + RC

(7)

where PV is the present value of the initial cost, i is the discount rate, N is the number of
periods, and RC is the recurring cost.
While the formula may initially appear daunting, there are several ways to
automate the process such as using a financial calculator, spreadsheet tool, or using endof-period compound interest factors available in many economic text books. We will use
a spreadsheet tool to simplify comparisons. The formulas above can be programmed into
a write-protected worksheet, allowing engineers to make quick calculations and evaluate
alternatives. The following is a screenshot of a possible spreadsheet-based analysis tool:

Figure 2. Excel®-Based Equivalent Annual Cost Tool
**Only change cells highlighted in yellow
**Lowest EAC is best option financially

Life Span (years)
Interest Rate

Option 1
Initial Cost
$
Recurring Cost
$
EAC
$

Option 2
Initial Cost
$ 21,000.00
Recurring Cost
$
EAC
$ 2,989.93

6,500.00
6,500.00

10
7.0%
Option 3
Initial Cost
$ 10,000.00
Recurring Cost
$ 3,125.00
EAC
$ 4,548.78

$7,000.00
$6,500.00
$6,000.00

Equivalent Annual Cost

$5,000.00

$4,548.78

$4,000.00

Option 1
Option 2

$3,000.00

$2,989.93

$2,000.00

$1,000.00

$-

32

Option 3

In Figure 2, three options are compared with differing initial and recurring costs, but
similar life spans and discount rates. Option 1 has no initial cost, but a high recurring
cost each year. The EAC for Option 1 is equal to the recurring cost. Option 2 has the
highest initial cost, but no recurring cost. The EAC for Option 2 is the initial cost spread
across the life span of the project (10 years), discounted by the interest rate of 7%.
Finally, Option 3 has a lower initial cost compared with Option 2 and a lower recurring
cost compared with Option 1. The EAC for Option 3 is the initial cost spread across the
life span of the project (10 years) plus the recurring cost per year. As shown in the bar
graph, Option 2 is the cheapest in terms of equivalent annual cost, followed by Option 3
and then Option 1. This is a good example of how decision makers may be misled by
high initial costs in favor of an affordable recurring cost. Even though Option 2 would
require a substantial investment up front, it is the cheapest option in terms of equivalent
annual cost.
Breakeven Analysis.
In addition to EAC, commanders may also want to know at what point options
become more expensive than one another. A breakeven analysis will show the best
option for a given range of time. Again, spreadsheet applications can easily be
programmed to display a line graph. The lowest line for any given time is the cheapest
option. The options have equal EACs at the intersection points. This method also allows
some sensitivity analysis by allowing the decision maker to determine at which time
period the options are equal. If there is uncertainty in the lifespan of the project or
equipment to be purchased, the breakeven analysis can help show at what range the
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project or expenditure is still viable. Figure 3 shows an example of a spreadsheet tool for
breakeven analyses:

Figure 3. Excel®-Based Breakeven Analysis Tool
**Only change cells highlighted in yellow
**On the graph, the lowest option is financially the best option for a given range of periods
Option 1
Initial Cost
$
Recurring Cost
$

6,500.00

Discount Rate

7%

Option 2
Initial Cost
$ 20,000.00
Recurring Cost
$
-

Option 3
Initial Cost
$ 10,000.00
Recurring Cost
$ 3,125.00

Option 2 versus Option 3
Breakeven Analysis

Option 1 versus Option 3
Breakeven Analysis

Option 1 versus Option 2
Breakeven Analysis

3.6

3.7

3.4

Periods

Periods

Periods

$25,000.00

$20,000.00

Equivalent Annual Cost

$15,000.00

Option 1
Option 2

$10,000.00

Option 3

$5,000.00

$0

2

4

6

8

10

12

14

16

18

20

Periods of Comparison

The same initial and recurring cost information from the EAC example were used. The
resulting analysis shows Option 1 is the cheapest for Year 0 to Year 3.4. Option 3 is
cheapest from Year 3.4 to Year 3.7. Option 2 is the cheapest past Year 3.7. Decision
makers must take into account the likely life span for a given project, as this could greatly
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influence the outcome. This graph allows the user to determine the sensitivity of time
effects in the analysis.
The breakeven lines shown in Figure 3 were developed using Equation 7 to
calculate the EAC for each option for each period of comparison. For example, Option 2
EAC for a life span of one year is $21,400. When we increase the life span to two years,
the EAC drops to $11,061.84. For three years, it is $7,621.03. As the projects are spread
out over longer periods of time, the resulting EACs are generally smaller. As shown by
Option 1, the EAC will not change if there is no initial capital cost. The EAC is equal to
the recurring costs each year. When we plot the EACs for all options across a range of
project life spans, we can see where one project becomes more expensive than the others.
Simple spreadsheet commands will even return the exact point where the EACs intersect,
as well as show the intersects graphically.
Validating DoD Cost Factors
The second area of methodology focuses on validating occupational illness cost
factors created by the DoD in 1988. Most previously cited methodology estimates the
direct and indirect cost of occupational illness by summing up what is spent to treat the
illness and what is lost due to a person having the illness. Direct costs include medical
expenses and disability payments. Indirect costs include forgone earnings, fringe
benefits, home production, lost productivity, turnover, and retraining. The basic total
illness cost equation is
Total Cost = Direct Cost + Indirect Cost

(8)

Equation 8 is the foundation of understanding occupational illness costs. We will
develop refined methodology in later sections that modify this basic equation as needed.
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As we develop specific methodology to quantify direct and indirect costs for Air Force
personnel, we will continually adjust this basic form of the equation to arrive at the final
model.
Direct Medical Costs.
While both medical and disability costs are considered to be direct costs, this
research project will focus solely on medical costs. Disability costs are normally paid
through the Department of Veterans Affairs, although there is some disability paid from
the DoD in the early stages of compensation for a service member. We will not consider
costs outside of the Department of Defense appropriations, particularly since the author is
attempting to show the impact to an organization funded through DoD appropriations.
Military medical expenses, consisting of military care and purchased care, were provided
to the author through a contracted data retrieval service for the Air Force Surgeon
General’s (AF/SG) office. Medical cost data is available for 1999 through 2008 and is
broken down into fiscal year, illness, rank, age group, gender, then year cost, and bed day
or frequency, depending if the cost was due to hospitalization or an outpatient visit. It is
important to note the medical cost data was provided in then year dollars. Then year
dollars show the cost of care in the year care was provided. Just as we cannot compare
the price of a loaf of bread from today with 30 years ago, we cannot compare medical
expenses occurring in different years. We need to adjust all costs to a base year, or
common year, so comparisons can be made. The following section addresses
normalizing direct medical costs to overcome this problem.
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Normalizing Direct Medical Costs.
Generally, the price of goods and services increase over time due to inflation.
The Bureau of Labor Statistics (BLS) provides inflation factors for goods and services,
allowing us to see the effects of inflation over time (bls.gov). One must normalize costs
occurring in different years before any analysis can be done. For our purposes,
normalization simply means adjusting costs from different time periods to a common
time period to account for normal increases in prices over time. The Consumer Price
Index will allow us to compare prices from different years and distinguish price increases
due to inflation and price increases due to simply higher cost. Unfortunately, BLS does
not provide a convenient tool for us to normalize medical costs, so we will create one.
SAF/FM has an online tool on the Air Force Portal to convert then-year dollars to
base-year dollars. Unfortunately, the Air Force cost conversion tool does not help
because of the unique nature of Defense Health Program (DHP) appropriations. DHP
appropriations are a mix of Operations and Maintenance, Procurement, Personnel, and
Research/Development/Testing dollars. There is no tool available to convert mixed
appropriations.
To overcome the mixed nature of DHP appropriations, we used the Consumer
Price Index – Medical (CPI-M) database (bls.gov). CPI-M measures the inflation of
medical costs over time. Table 4 shows the CPI-M inflation data as well as the normal
CPI inflation data for 1999 through 2008 (Ibid). We use these values to build an index
allowing us to convert then-year medical costs to a base year value equal to the year
2008.
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Table 4. CPI-M Base Year Conversion Factors (bls.gov).
Medical CPI Medical CPI Traditional CPI Traditional CPI
Medical CPI
Year Index Value Inflation Value Index Value Inflation Value Normalization Factor
1998
238.1
162.0
1999
246.5
3.5%
164.7
1.7%
1.464
2000
255.6
3.7%
169.3
2.8%
1.412
2001
267.2
4.5%
175.6
3.7%
1.350
2002
279.8
4.7%
177.7
1.2%
1.289
2003
292.7
4.6%
182.6
2.8%
1.233
2004
303.8
3.8%
186.2
2.0%
1.188
2005
317.0
4.3%
191.7
3.0%
1.138
2006
329.8
4.0%
199.4
4.0%
1.094
2007
343.8
4.2%
203.6
2.1%
1.049
2008
360.8
4.9%
212.5
4.4%
1.000

The base year conversion index was built by dividing the CPI-M inflation factor
obtained from the Bureau of Labor Statistics for 1999 through 2007 by the inflation
factor for 2008. The BLS set 1984 as a base year equal to 100. Any increase or decrease
in prices since 1984 will result in an increase or decrease from this base value of 100.
For example, in Table 4, the inflation factors for years 1999 and 2008 are 246.5 and
360.8, respectively. We use Equation 9 to calculate the conversion factor to normalize
then year costs to a given base year:
1 + ((Base Year Index Value – Then Year Index Value) / Then Year Index Value)

(9)

To clearly demonstrate this formula, Equation 10 calculates the normalization factor for
1999:
1 + ((360.8 – 246.5) / 246.5) = 1.464

(10)

Normalization factors allow us to modify costs occurring in years 1999 through 2007 to a
base year of 2008, as shown in Equation 11:
NDC = WCPIM * DC
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(11)

where NDC is the normalized direct medical cost, WCPIM is the weighted CPI-M
normalization factor and DC is the direct cost reported in then year dollars by AF/SG.
Table 4 and Figure 4 demonstrate the necessity of building a special conversion
index for medical costs. The data and figure clearly shows that medical costs rise much
faster than the traditional CPI index. Using the traditional CPI index instead of the CPIM index would result in underestimating the normalized costs when converting to a 2008
base year.

Figure 4. Yearly Comparison of Medical and Traditional CPI
Inflation (bls.gov).
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Now that all costs are in a common base year of 2008 dollars, we can concentrate on
what portion of the costs are due to occupational illness.
Mean Attributable Factors.
According to previous research cited in the literature review, Leigh et al,
Markowitz et al and Steenland et al developed methodology to determine what portion of
illnesses can be attributed to occupational exposure. The attributable factors are specific
to each type or category of illness. Leigh determined the mean value of the attributable
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factor is appropriate to use for occupational illness estimations (Leigh, 2008). See
Appendix A-1 for a complete list of all illnesses and mean attributable factors included in
this project. Table 5 provides a subset of illnesses as an example. As shown below, we
see that 5.5% of Pulmonary Tuberculosis cases may be the result of occupational
exposure. All further occupational illness cost analysis in this thesis is founded upon the
mean attributable factors developed by previous researchers.

Table 5. Abbreviated List of Illnesses, ICD Codes and
Attributable Factors.
Mean
Attributable
Factor
ICD-9
Illness
Pulmonary Tuberculosis
011
5.5%
Lymphoid leukemia
204
1.8%
Parkinson's disease
332
2.0%
Hypertensive heart disease
402
7.5%
Chronic bronchitis
491
15%
Asthma
493
16%
Chronic hepatitis
571.4
0.8%
Chronic renal failure
585
11.4%
Mesothelioma
NA
100.0%
With mean attributable factors, we can estimate the portion of normalized direct
medical costs resulting from occupational illness, as shown in Equation 12:
NOIDC = MAF * NDC

(12)

where NOIDC is the normalized occupational illness direct cost, MAF is the mean
attributable factor, and NDC is the normalized direct cost calculated in Equation 11. For
example, if there was $10,000 spent on care for Chronic Bronchitis in 2008, we can
multiply the cost by the mean attributable factor for Chronic Bronchitis, 15% as shown in
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Table 5. The result is $1,500, which is the portion of medical costs for Chronic
Bronchitis theoretically resulting from occupational illness. Mean attributable factors are
a critical component in the conversion of direct medical costs to occupational illness
costs. The factors also apply to bed days and illness frequencies, as shown next.
Inpatient Versus Outpatient Medical Costs
The preceding methodology allows us to develop direct medical costs resulting
from occupational illness. The available data also shows inpatient costs and ambulatory
costs. Inpatient costs are the result of admittance to a medical treatment facility and will
result in some number of bed days for a particular stay. Inpatient cases will be used to
validate the hospitalization cost factor shown in DoDI 6055.07.
On the other hand, ambulatory medical costs result from an illness that may not
be severe enough to admit the patient, such as a routine doctor appointment or “sick call”.
Ambulatory medical costs will be used to validate the no lost time cost factor shown in
DoDI 6055.07. Ambulatory costs do not result in bed days. However, the data provided
by AF/SG shows the frequency of each visit for the list of occupational illnesses shown
in A-1 of the appendix.
The number of bed days and frequency of ambulatory visits will also be
multiplied by the mean attributable factors. This step is necessary to properly analyze the
modified direct cost of occupational illness with the resulting bed days or visits to a
hospital.
No Lost Time Factor Validation
To validate the DoD cost factor for no lost time, we will perform a simple linear
regression. We will regress the normalized occupational illness direct medical cost from
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Equation 12 against the frequency of visits due to occupational illness. We will then
compare the β1 coefficient from the regression with the DoD cost factor to determine if
there is a statistically significant difference between the two estimates, as shown below in
Equation 13:
NOIDC = β0 + β1FOI

(13)

where NOIDC is the occupational illness direct cost from Equation 12, FOI is the
frequency of illness visits due to occupational illness, and β1 serves as the validation cost
factor to compare with existing DoD information. The cost factors provided by DoD are
20 years old. As such, we will apply normalization factors using the same procedure
discussed earlier to normalize the factors to a base year of 2008.
Modeling Indirect Costs of Occupational Illness.
Indirect costs may be modeled based on hospitalization medical costs and the
DoD cost factor for hospitalization. According to DoDI 6055.07, the hospitalization
factor represents total cost of illness. Remember from Equation 8 that total costs equal
direct costs plus indirect costs. The factor developed in 1988 was $466 per day for
enlisted and commissioned personnel. We will estimate the indirect portion using actual
medical costs, bed days, and mean attributable factors. Equation 14 shows how indirect
costs will be calculated:
OIIC = (BDOI * HCF) – NOIDC

(14)

where OIIC is the occupational illness indirect cost, BDOI is the number of bed days for
a patient due to occupational illness, HCF is the DoD hospitalization cost factor and
NOIDC is the normalized occupational illness direct cost. The results for each
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observation allow us to have an indirect and direct cost value for each incidence of
occupational illness. Now we can validate the DoD cost factor for hospitalization.
Hospitalization Cost Factor Validation
We must determine if the DoD cost factor is robust enough to capture direct
medical costs and still have allocation remaining for indirect medical costs. If the results
from Equation 14 are largely negative, we may be able to conclude the cost factor is not
accurate enough to total costs, or even the direct portion of medical costs.
As shown in the literature review, indirect costs have been estimated to be as high
as $6 to $53 per dollar of direct cost (WSES.com) or as low as $0.59 per dollar of direct
cost (Leigh, 1997). Using Equation 15 we can create a new cost factor with the existing
DoD cost factor and direct medical cost data. The new factor will allow us to compare
the two existing indirect cost estimates and lend validity to one or the other, based on our
results:
OIIC = β0 + β1NOIDC + ε

(15)

where OIIC is the occupational illness indirect cost from Equation 14, NOIDC is the
direct cost resulting from occupational illness, and β1 serves as our new indirect
occupational illness cost factor estimate. The coefficient β1 will represent the dollar
amount of indirect costs that results from each dollar increase in direct costs. In the
following sections, the author will normalize the data and perform the analysis, as well as
discuss results.
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IV. Data Analysis
Cost Comparison Tool
The data analysis for the cost comparison tool developed for Hill AFB
bioenvironmental engineers is fairly straightforward. The analysis will be based on two
scenarios the engineers provided as examples of current processes. The current process
and results will be discussed and then compared with results obtained from using the new
tool discussed in Chapter III.
Current Process
Bioenvironmental engineers conduct industrial hygiene visits to certain work
centers on a recurring basis. Their job includes ensuring safe work practices are followed
and ensuring workers are protected from occupational hazards. The commander directed
engineers to evaluate one process for each work center while the engineers conduct
industrial hygiene surveys. The engineers seek out one process that may be improved
through a reduction in exposure to a hazard. The process improvement is typically
justified by cost savings of time, material, or manpower. However, if the new process is
more expensive even though it is safer, the proposal may not get funded.
To calculate the costs of existing and proposed processes, engineers developed a
basic spreadsheet. The spreadsheet tracks expected cost savings and initial capital
requirements. Engineers then compare this to the cost of keeping the existing process in
place. Table 6 below shows an example of the analysis currently done at Hill AFB. The
existing tool is a very simple process that compares costs and expected savings.
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Table 6. Hill AFB Cost Comparison Tool, Example 1.
Office
571 AMXS/MXDPAA

Workplace

Cat:

A-10 Sheet Metal, Hanger 1

1

PPE Type

# In Use

Replacement
Frequency Per
Year

Activity
Number Activity

1

Chemical stripping

Butyl Ruber Gloves

3M Full Face air purifying

Annual PPE
Cost per Activity

Unit Cost

5

12

$

12.00

$

720

15

2

$

275.00

$

8,250

3M Half Face air purifying

5

10

$

15.00

$

750

3M P100 Particulate

15

2

$

8.00

$

240

3M Multi-Gas/P100

5

10

$

20.00

$

Current Process

Activity
Number Activity

1

Chemical stripping

Activity
Number Activity

1

Chemical stripping

Cost per
Exam

Exam Type

Occ Physical

Engineering Control

CNC Process

$

400.00

Freq per
year

Number of
workers

1

15

1,000
Subtotal

$

10,960

Annual Exam
Cost per Shop

$

6,000

Current Process

Subtotal

$

6,000

Current Process

Total

$

16,960

$

1,000,000

Total Estimated
Engineering
Cost

Estimated
Cost

$

$ 1,000,000.00

New Process

1,000,000
Total

Projected
Savings/Loss

($983,040)

For example, Table 6 is broken down into three major activities. The first two activities
show the current process. The last activity shows the proposed process. Many cells of
the spreadsheet were keyed in manually instead of using basic spreadsheet formulas to
calculate subtotals. More manual processes introduce the likelihood of error. The new
process is estimated at $1,000,000, while current processes cost $16,960. The difference
between the two estimations is $938,040.
We suggest a simple solution for this problem. The engineers should utilize basic
spreadsheet formulas to subtotal each item, showing all steps of calculations to allow
outsiders to quickly ascertain the intent of the process. We also recommend utilizing the
notes or comments function, allowing the end user to add clarification for each step in the
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cost/benefit analysis. Documentation is absolutely critical to ensure the analysis is done
properly.
Whatever spreadsheet capabilities are employed to calculate costs and benefits, it
seems inappropriate to compare the initial cost of a new process with the annual cost of
the existing process. As shown, in Table 6, the cost of a new process is $1,000,000. We
do not know if this is a onetime cost or a recurring cost. This information is critical to
properly compare the new process with the current process, and could greatly influence
the answer. Also, other options may be available with lower initial costs but higher
recurring costs. We showed in Chapter III how a higher initial cost could ultimately be
the cheaper option, based on the projected lifespan and other factors. Next, we will see
how using a simple model and inputs for initial and recurring cost can make a
cost/benefit analysis simple, effective, and very transparent for the decision maker.
Validating Cost Comparison Tool
The following sections attempt to validate the new cost comparison tool
demonstrated in the Methodology section by using it to analyze the analyses submitted by
Hill AFB engineers. We start with validating the results of Table 6, where engineers
concluded the new process would lead to expected losses of $983,040. Figure 5 below
shows the new cost comparison tool in action, comparing the costs from an equivalent
annual cost standpoint.
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Figure 5. Validation of Cost Comparison Tool, Example 1.
Life Span (years)

Best Choice

20

Option 1
Initial Cost

$

Recurring Cost
EAC

Option 1

**ONLY CHANGE ITEMS HIGHLIGHTED IN YELLOW**

Option 2
-

Option 3

Breakeven Analysis

Initial Cost

$ 1,000,000.00

Initial Cost

$ 500,000.00

Option 1 versus Option 2

$ 16,960.00

Recurring Cost

$

Recurring Cost

$ 10,000.00

Option 2 versus Option 3

$ 16,960.00

EAC

$

EAC

$ 57,196.46

Option 1 versus Option 3

94,392.93

####### years
####### years
####### years

EAC Comparison
$94,392.93

$100,000.00

Equivalent Annual Cost

$90,000.00
$80,000.00
$70,000.00
$57,196.46

$60,000.00

Option 1

$50,000.00

Option 2

$40,000.00

Option 3

$30,000.00
$16,960.00

$20,000.00
$10,000.00
$-

Breakeven Analysis
$1,200,000.00

Equivalent Annual Cost

$1,000,000.00
$800,000.00
$600,000.00

Option 1
Option 2

$400,000.00

Option 3

$200,000.00
$0

2

4

6

8

10

12

14

16

18

20

Years of Comparison

In this case, shown by Figure 5, the current process is cheaper even when the timeline is
spread out to twenty years. The extremely high initial cost of the new process prohibits
justification on a financial consideration alone. Option 3 is a hypothetical example,
where the initial cost is half as much as the proposed option, with $10,000 recurring
costs. This option is also prohibitively expensive. While the end results are the same as
the engineers’ analysis, the true cost differential per year is approximately $77,000
instead of the flat loss of over $980,000 reported earlier. The breakeven analysis fails to
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return a useful point of intersect, showing “###” because the annual costs never cross
each other. Option 1 is always better than the others, within a realistic timeline.
The example in Table 7 shows another analysis conducted by Hill AFB engineers.

Table 7. Hill AFB Cost Comparison Tool, Example 2.
Activity
Number Activity

2

noise/mechanical

# used
per year

PPE Type

Ear Plugs Disposable

500

Unit Cost

$

PPE Type

PPE Type

0.50

Annual PPE
Cost per Activity
$

Current Process

Activity
Number Activity

2

noise/mechanical

Cost per
Exam

Exam Type

Occ Physical

$

400.00

Freq per
year

Number of
workers

1

15

$

Current Process

2

pneumatic tools

mech work

$

250.00

6,000.00
Subtotal
$

6,000.00

Annual Exam
Cost per Shop

Current Process

Activity
Number Activity

250.00

Subtotal

Total

$

6,250.00

5,000.00
5,000.00
Total
$

20,000.00

Estimated
Cost

Engineering Control

Noise suppression device for air tools
Rubber Isolation mounts
Isolation barriers

$

$
$
New Process

10,000.00

Projected
Savings/Loss

($13,750.00)

As we see in Table 7, the new process is estimated to be $13,750.00 more expensive than
the current process. The upfront cost of the new equipment is compared directly with
the ongoing cost of personal protective equipment and occupational physicals. This
proposal is much more appropriate to compare as equivalent annual costs due to the
higher fidelity and lower magnitude of the new process and its estimated costs.
Figure 6 clearly shows that although the current process is cheaper in the first year
due to capital investment requirements, the new process becomes the best alternative
financially as the initial investment is spread out over a realistic timeline. In this case, we
chose 10 years for the lifespan of the equipment. Of course, actual timelines for
equipment vary with use and care.
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Figure 6. Validation of Cost Comparison Tool, Example 2.
Life Span (years)

Best Choice

10

Option 1
Initial Cost

$

Recurring Cost

$

EAC

$

Option 2

**ONLY CHANGE ITEMS HIGHLIGHTED IN YELLOW**

Option 2
-

Option 3

Breakeven Analysis

Initial Cost

$ 20,000.00

Initial Cost

$ 10,000.00

Option 1 versus Option 2

6,250.00

Recurring Cost

$

Recurring Cost

$ 3,125.00

Option 2 versus Option 3

6,250.00

EAC

$ 2,847.55

EAC

$ 4,548.78

Option 1 versus Option 3

-

3.7
3.7
3.7

years
years
years

EAC Comparison
$7,000.00

$6,250.00

Equivalent Annual Cost

$6,000.00
$5,000.00

$4,548.78
Option 1

$4,000.00

Option 2

$2,847.55

$3,000.00

Option 3

$2,000.00
$1,000.00
$-

Breakeven Analysis
$25,000.00

Equivalent Annual Cost

$20,000.00
$15,000.00
Option 1

$10,000.00

Option 2
Option 3

$5,000.00
$0

2

4

6

8

10

12

14

16

18

20

Years of Comparison

Figure 6 shows that the proposed option is clearly cheaper than the current process after
3.7 years. As long as the new equipment is expected to last 3.7 years or longer, the new
process should be chosen over the existing process. This decision is purely financially
driven, and the author acknowledges there may be other factors in the decision process.
Option 3 is hypothetical, with half the required investment of Option 2 and half the
required recurring costs of Option 1. This option is also financially better after 3.7 years.
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Based on the two examples provided by Hill AFB engineers, we feel the proposed
cost comparison tool, emphasizing equivalent annual cost and breakeven comparison,
offers a much better analysis than the simple manual entry spreadsheet currently in use.
We now direct our efforts to the DoD cost factor validation.
No Lost Time Cost Factor
To begin the data analysis, we will focus on the no lost time cost factor provided
by the DoD in 1988. The no lost time factor represents the expected cost per occurrence
of occupational illness. The cost factor was originally $120 per day in 1988. We can
easily adjust the factor to take into account normal cost growth for medical services, just
as we did for the direct medical costs in Equation 9 from Ch III. Equation 16 shows the
calculation:
$120 * (1 + (360.8 – 134.4) / 134.4) = $322.14

(16)

where $120 is the cost factor in 1988, 360.8 is the CPI-M index value for 2008, and 134.4
is the CPI-M index value for 1988. From this calculation, we show that the DoD cost
factor is $322.14 when normalized to the year 2008. This normalized cost factor will be
used throughout the data analysis for no lost time cases.
Military Care and Purchased Care Results
Now that the factor has been normalized, we will regress the number of
occupational illnesses on the normalized occupational illness costs for ambulatory cases
from FY1999 through FY2008. The resulting β1 coefficient from the regression can then
be compared to the normalized DoD cost factor. As noted in Equation 13, our regression
equation is NOIDC = β0 + β1FOI + ε, where NOIDC is the normalized occupational
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illness direct cost and FOI is the frequency of occupational illness. The author uses JMP
7.0/8.0 and Stata 10 statistical software throughout the project.
As the initial regression results show, the model gives good indication that some
type of singular cost factor for each occurrence is certainly possible. The model has an
adjusted R2 value of 0.887002, which simply means the model explains nearly 89% of all
variance in the data. The dependent variable, normalized occupational illness cost,
displays heteroskedasticity. Heteroskedasticity means non-constant variance. We can
expect non-constant variance with medical costs, because each case will be greatly
affected by many factors. Medical procedures for the same type and intensity of illness
can vary based on where the treatment is provided, the skills and knowledge of the staff,
and the actions of the patient. We address the heteroskedasticity and other diagnostics
later.

Figure 7. Regression of Illness Costs on Frequencies, Military
and Purchased Care.
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The outliers shaded in dark gray are all due to Tinnitus cases all within the same year.
The twelve data points fall outside the general linear relationship. Based on the hundreds
of cases of Tinnitus and hearing loss in the data, we assume these cases do not represent
relative cost/frequency ratio reliability that is shown by the rest of the model. However,
we have inadequate case-level information that could justify excluding the cases. As
such, we leave the outliers in place and note their existence in the regression. Table 8
shows the parametric estimates for the regression plot in Figure 7.

Table 8. Illness Costs/Frequencies, Military and Purchased
Care.
Equation: NOIC = β0 + β1 FOI
Adjusted R square =
0.887
N = 71,872
Variable
Estimate Standard Error T Ratio Probability
Intercept
-26.87
14.32
-1.88
0.0606
Frequency of Occ Illness
235.58
0.31
751.11
0.0000
The results allow us to directly compare the DoD cost factor of $322.14 with the new
cost factor based on actual medical cost data across 71,872 observations. The resulting
regression coefficient of $235.58 is much less than $322.14. Although the t-statistic and
adjusted R-square results show this model is reliable, we do not yet have enough
information to invalidate the DoD factor.
The medical data contains cases where medical care was provided at a military
treatment facility as well as purchased from non-military treatment facilities. Now, we
will determine if there are any differences in the cost factor based on where the care was
provided. We perform similar regressions grouping cases by whether or not the care was
provided by a military facility.
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Military Care Results
We can quickly manipulate the data to exclude observations where costs were
incurred at non-military treatment facilities and regress the remaining 42,651
observations in the same manner as before. As shown in Figure 8, the results are largely
similar, to include the outlying Tinnitus cases noted earlier.

Figure 8. Regression of Illness Costs on Illness Frequencies,
Military Care.

Table 9 below also shows promising results for the model. While the new cost factor is
slightly higher than the previous cost factor, it is still below the DoD cost factor of
$322.14.
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Table 9. Parametric Estimates: Illness Costs on Illness
Frequencies, Military Care.
Equation: NOIC = β0 + β1 FOI
Adjusted R square =
0.921
N = 42,651
Variable
Estimate Standard Error T Ratio Probability
Intercept
258.87
19.78
13.09
<0.0001
Frequency of Occ Illness
251.59
0.36
705.63
0.0000
The intercept and frequency are both statistically significant, as shown by the high t-stats.
One might argue for forcing the regression through the origin, because with no illness,
there should be no cost. However, there will always be some cost of healthcare, with or
without patients. Also, the variable is statistically significant, so we will leave it in place.
Now, we will perform similar actions with only the observations resulting from
purchased care to see if there is much difference.
Purchased Care Results
The results of observations where medical costs were incurred from non-military
treatment facilities differ significantly. The differences are not evident from the
regression plot below in Figure 9, as the model clearly demonstrates a similarly linear
relationship with few outliers.
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Figure 9. Regression of Illness Costs on Illness Frequencies,
Purchased Care.

In this case, the outliers had no discernable pattern of illness or other factors. Some
people’s care will obviously cost more than others. Such is the dilemma of analyzing
medical cost data.
Table 10 shows the parametric results for the regression of purchased care and
frequencies of occupational illness. Note the much lower cost factor of $115.47
compared to the normalized DoD cost factor of $322.14. Also, this factor is much lower
than the direct care costs incurred at a military treatment facility. There is strong
explanation of variance, with an adjusted R-square value of 0.89 across 28,843
observations.
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Table 10. Parametric Estimates: Illness Costs on Illness
Frequencies, Purchased Care.
Equation: NOIC = β0 + β1 FOI
Adjusted R square =
0.890
N = 28,843
Variable
Estimate Standard Error T Ratio Probability
Intercept
-9.70
6.05
-1.60
0.1089
Frequency of Occ Illness
115.47
0.24
483.21
0.0000
The previous regressions show a wide range of cost factors compared with the
established DoD cost factor for no lost time. It may be of little use to develop a cost
factor for each demographic group and illness. The results would be cumbersome and
would likely not be used for rough order of magnitude (ROM) estimates. However, if we
can show the existing cost factor is accurate across 74 specific illnesses, we feel the
combined factor will be more useful for medical cost estimations. If we find the existing
DoD cost factor is inaccurate, we will propose an updated factor for DoD to take under
consideration.
Cost Factor Comparison
Table 11 recaps the cost factors to this point. We will compare the resulting
factors in order to recommend the best factor for the DoD to use when estimating medical
costs of occupational illness resulting in no lost time.

Table 11. Costs Factor Comparison.
Value Intercept Adjusted R Square
Cost Factor
DoD
$322.14
NA
NA
Military and Purchased Care $235.58
-26.87
0.887
Military Care
$251.59 258.87
0.921
Purchased Care
$115.47
-9.70
0.890
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Table 11 shows that all three models developed in this project have high explanation of
variance, as noted by the adjusted R-square values. The combined military and
purchased care regression resulted in a statistically insignificant intercept. Also, the
frequency of military care versus purchased care is approximately 2 to 1, meaning active
duty members are twice as likely to receive care at a military treatment facility as at a
civilian treatment facility.
The likelihood of direct care or purchased care may also have much to do with
geographical location and type of illness. Some military treatment facilities have been
closed, outsourcing most or all care to the local community. For example, the Air Force
Academy recently closed emergency services and inpatient services, forcing patients to
go downtown for care (Press, 2008). Some military treatment facilities do not have the
specialty care necessary in some instances, and refer patients off base for specialized
care. Again, the Air Force Academy can be used as an anecdotal example based on the
author’s personal experience.
The combined military and purchased care factor is $235.58 per day, with an
extremely tight confidence interval. Based on the standard error of 0.31 obtained in the
regression, the 95% confidence interval is $234.97 to $236.20. Once we determine the
confidence interval, we can properly compare the new factor with the existing DoD
factor. If the DoD factor falls outside this confidence interval, we conclude that the DoD
factor is statistically significantly different. Of course, it is obvious $322.14 does not fall
between $234.97 and $236.20, so we conclude the DoD cost factor overestimates the
direct medical cost of ambulatory visits based on our data set of over 71,000 observations
across all ranks, genders, and age groups for the last 10 years. We further conclude the
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DoD should adopt a new cost factor of $235.58, rounded up to $236 for ease of
calculations, for no lost time medical cost estimation.
Now that we have decided on a final model, we will run two regression diagnostic
tests. The first test will determine the normality of the dependent variable, normalized
occupational illness cost. The second test will check for heteroskedasticity.
Normality checks for a data set of 70,000 plus observations are challenging.
Some statistical software packages and computer systems simply cannot handle the task.
We used the Shapiro-Wilk test and the histogram function in Stata 10. Appendix A19
shows the normality results. To summarize, the normalized occupational illness costs are
not from a normal distribution. This is not surprising considering the data manipulation
required to get to the values used in the regression.
In the heteroskedasticity check, we plotted the residuals against the predicted
values for the regression equation. The cone shaped scatter plot in A20 notes moderate
heteroskedasticity. To overcome this, we regressed the same equation with robust
standard errors. The results of this regression can also be found in A20. The most
significant change is to the standard errors. Otherwise, the cost factor remains
unchanged.
Hospitalization Cost Factor
Now the research shifts to validate the DoD cost factor for hospitalization. This
factor is much more complicated, because it attempts to estimate direct and indirect costs
that may happen as a result of military or purchased care.
Following the same normalization process as Equation 16, the DoD cost factor of
$466 is normalized to $1,250.99 in 2008 base year dollars. This normalized cost factor is
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the estimated cost per bed day for an occupational illness, to include direct and indirect
costs. We will refer to this factor as a total cost factor because the total cost of illness
includes direct and indirect costs. In order to divide the total cost factor into direct and
indirect components, we will utilize the medical cost data for hospitalizations for active
duty Air Force personnel from 1999 to 2008. The total cost per bed day, normalized to
2008 dollars, multiplied by the number of bed days will be the total cost of illness. The
direct costs from the medical cost data will then be subtracted to leave only those costs
supposedly due to indirect costs. The methodology of the calculations was laid out
earlier in Equation 14.
Negative Indirect Costs
Preliminary analysis of the hospitalization data revealed a serious problem. Total
costs are supposed to encompass direct and indirect costs. However, based on the 3,983
observations of inpatient medical expenses from 1999 to 2008, the vast majority of
reported expenses outstripped the DoD total cost factor estimate. In other words, the
DoD “total” cost factor was not high enough to cover the direct medical expenses, let
alone indirect costs associated with occupational illness. Table 12 shows the preliminary
analysis of negative indirect illness costs.

Table 12. Percentages of Negative Indirect Illness Costs.
Purchased Care
Military Care
Total

Total Observations
2,346
1,637
3,983

Negative Observations
1,799
1,578
3,377

Percentage
76.7%
96.4%
84.8%

Table 12 clearly demonstrates the vast majority of hospitalizations over the past
10 years cannot be accurately estimated by the DoD total cost factor. The DoD total cost
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factor seems inaccurate to model the actual medical expenses without having any left
over to consider true indirect costs such as employee turnover, lower productivity, and
costs to society in general. Purchased care costs surpassed the DoD estimates in 1,799 of
the 2,346 observations, or 76.7% of the time. Military care costs surpassed the DoD
estimates in 1,578 of the 1,637 observations, or 96.4% of the time. This again leads to an
interesting situation where purchased care seems less expensive than military care.
Finally, aggregating the data, 3,377 of the 3,983 total observations, or 84.8% of the cases
were higher than DoD total cost factors would predict.
DoD Cost Factor Invalidation
The DoD total cost factor for hospitalization is supposed to estimate total costs:
direct medical costs plus some amount of indirect costs. Existing indirect cost estimates
range from $0.59 to $53 per dollar of direct cost, as noted in earlier chapters. While we
cannot say which end of the spectrum is more appropriate, we can say with certainty that
the indirect costs are not negative. The DoD total cost factor is not valid on the basis that
it does not adequately capture even the direct medical costs of occupational illness. One
cannot regress the data as proposed in Equation 15 when the dependent variable is
predominantly negative.
Proposed DoD Cost Factor Update
Based on the invalid DoD cost factor, we cannot use the existing data to
determine an occupational illness indirect cost factor. However, we can update the DoD
total cost factor for direct medical costs only. As such, the planning factor for DoD cost
estimating should be displayed in a manner that analysts fully understand that no indirect
costs are included in the estimating factor. To be clear, the DoD total cost factor for
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hospitalization should be renamed to the DoD direct medical cost factor for
hospitalization.
The process for determining a valid direct medical cost factor is fairly
straightforward. In fact, we will follow closely with the methodology used for validating
the DoD no lost time cost factor. Instead of using the frequency of occupational illness,
we will use the bed days resulting from occupational illness. Otherwise, the steps in both
analyses are comparable. We will proceed by considering all treatment observations,
military care and purchased care. Then, we will separate the two categories to see if there
is any marked difference. Finally, we will recommend a new DoD cost factor to estimate
direct medical expenses.
Military and Purchased Care
We have a total of 3,983 observations of medical costs incurred as the result of
hospitalization of active duty Air Force members from 1999 to 2008. The reason for
hospitalization is due to a primary diagnosis of the illnesses included in Appendix A-1.
The regression equation is:
NOIC = β0 + β1BDOI + ε

(17)

where NOIC is the normalized occupational illness medical cost and BDOI is the number
of bed days resulting from occupational illness. The resulting regression scatter plot and
statistics show the relationship between cost and bed days.
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Figure 10. Regression of Military and Purchased
Hospitalization Costs on Bed Days

Figure 10 shows a simple linear regression of combined military and purchased
medical care costs on bed days, both attributed to occupational illness. While both the
intercept and bed days variables are statistically significant, as shown in Table 13, the
adjusted R-square of 0.214 does not bode well for the initial model.

Table 13. Initial Total Cost Factor Validation.
Equation: NOIC = β0 + β1 BDOI
Adjusted R square =
0.214
N = 3,982
Variable
Estimate Standard Error T Ratio Probability
Intercept
774.18
33.12
23.37
<0.0001
Bed Days from Occ Illness
1005.55
30.54
32.92
<0.0001
In Table 13, the beta coefficient for bed days due to occupational illness is $1,005.55.
This tells us that for each additional bed day, the occupational illness cost will increase
by $1,005.55. Remember back to our normalized DoD total cost factor of $1,250.99.
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The regression results show a factor that is lower by $245.44. It is tempting to consider
this difference as the elusive indirect costs we sought earlier, as demonstrated by
Equation 14. However, the model is misspecified at this point and any regression results
at this point would be inaccurate. Perhaps the bed days do not explain enough of the
variance in medical costs. While we do not have individual level data for medical costs,
we do have some additional demographic indicators. Next, the model will be augmented
by more independent variables in an attempt to better explain variance.
One approach is to include all possible variables in an equation to see if anything
is statistically significant. The so-called “kitchen sink” approach relies on results of
statistical software versus forethought and theoretical modeling (Wikipedia). Once all
variables are included, the model is reduced down to statistically significant variables.
The problem with this approach is that model misspecification may occur through
inclusion of irrelevant variables, simply for the sake of including whatever data is
available. We feel we should make use of available data, provided the model is grounded
in theory.
The data structure allows us to consider whether certain diseases may behave
differently in terms of accruing costs. We are able to aggregate the list found in A1 into
six broad categories: respiratory diseases, cancer, circulatory diseases, high frequency
diseases, nervous system diseases, and “other” occupational diseases. The “other”
category simply contains illnesses attributable to occupational exposure but not otherwise
fitting into the other five categories. It is possible one illness category drastically
influences the results. We can run regressions including only a specific category or
excluding the category. Additionally, we can break out occurrences into purchased care
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or military care. The table in A2 summarizes the regression results from the
aforementioned possibilities. Out of the 39 simple linear regressions, only a few
produced somewhat promising results as noted by the adjusted R-square value. For
nearly every category, purchased care resulted in a much lower bed day coefficient, and
adjusted R-square value as well. Clearly, these models do not convey the results we
hoped for, either.
Data Appearance
Looking at the raw data can provide much useful information. Consider the
following figures, showing a three dimensional cube of illness category, occupational
illness cost, and occupational illness bed days. Figure 11 shows a “cube” from the
statistical software package, JMP 8.0. The figure allows us to quickly determine if there
are any notable relationships between the major category of illness and cost or bed days.
If one illness category stands out or does not behave as the others, we may need to
explain the variation before proceeding. Figure 11 shows how the categories of illness
differ in the spread of occupational illness costs.

Figure 11. Illness Categories and Cost Scatterplot.
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As shown above, the distribution and variance of costs differ somewhat between
categories of illness when military and purchased care observations are combined.
Nervous system disease appears to have fewer observations than the other categories.
Otherwise, the categories all follow similar patterns: many observations clustered in the
lower cost range, with sporadic outlying observations at extreme cost levels.
A similar figure in the appendix, A3, shows a graph for all observations
substituting bed days for cost. Graphs A4 through A7 display the same concept but
breaking out military care and purchased care separately. Looking at A3 through A7, we
see the spread of bed days among the categories of illness are similar as well. One
notable difference between military care and purchased care is that the costs for
purchased care seem to be a much tighter distribution at the lower levels than military
care. A possible explanation of this stems from the military healthcare billing system.
As active duty patients are cared for in non-military treatment facilities, the charges for
the care are mostly predetermined by agreements for care through the Tricare insurance
program. Fees for procedures are mostly agreed upon through memorandums of
understanding, which allow the providers to be in a Tricare network. The insurance
billing resembles “flat rate” billing as opposed to what a civilian counterpart would be
charged for the same visit. Otherwise, no readily apparent differences exist in the data.
ROM Hospitalization Model Specification
Based on our conclusion that there are no discernible differences between the
illness categories or source of care, we do not have reason to divide the data or create
separate cost factors. We submit the results contained in Table 13 stand as our updated
DoD Direct Medical Cost Factor. Admittedly, a single cost factor developed from the

65

limited direct medical cost data available is not optimal. We provide rationale for the low
explanation of variance, or low R-square value, obtained in our final model. The
variance of occupational illness cost depends on other factors besides bed days; data we
simply do not have access to in order to refine our model specifications. The model can
be used as a heuristic approach in order to gain a rough order of magnitude for direct
medical costs. The model is still unable to account for indirect medical costs. However,
the existing choices of indirect medical cost factors may still apply. The decision maker
must determine which end of the spectrum to use, ranging from $0.59 to $53.00 per
dollar of direct medical costs.
Parsimony Versus Specificity
One intent of this research project was to provide a clean, versatile cost per bed
day factor. The factor should apply across all variables: age, gender, rank, source of
treatment, disease, and number of bed days. However, based on the previous heuristic
modeling approach, such an endeavor to create a single robust cost factor is nearly
impossible. We would expect high resistance against a model where we controlled for all
variables. The model would not be very useful for rough order of magnitude cost
estimating, which we believe is the basic intent of the DoD cost factors.
Although the following modeling analysis will hardly be convenient as a direct
medical cost estimation tool, we will use all the data at our disposal and attempt to
provide a more complete approach. The final model specification is complex, but so is
the nature of occupational illness. We feel costs differ depending on the age of the
patient. We feel costs differ based on the specific or general type of disease in question.
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What this new model loses in convenience, it gains in explaining significantly more of
the variation of our earlier model.
In addition to using demographic variables and specific diseases, we tried using a
log-level model specification. Logarithmic transformation of the dependent variable is
helpful because it can compress the range of costs normally experienced in our data set.
We also set aside the occupational illness attributable factors to see if normalized cost
would lead to better results. Each of these options was used across military care,
purchased care, and a combination of military and purchased care. Finally, we used major
disease categories, minor categories, sub minor categories, and specific disease lists. The
final model is a result of nearly two hundred iterations before arriving at the optimal
solution.
Equation 18 shows the final model specification, with the regression results
following. The full list of diseases included in the disease vector can be found in the
Appendix, A-8.
NOIC = β0 + β1OIBD + β2Age + β3Diseasesi

(18)

where NOIC is the normalized occupational illness cost, OIBD is the number of bed days
resulting from occupational illness, Age is a continuous age variable, and Diseasesi is an
xi vector of 25 specific illnesses listed in Appendix A-8. These 25 illnesses were the
statistically significant illnesses out of a list of over 200.
The final model performed well when only military care observations were used.
This reduced our number of observations from 3,983 to 1,637. However, the high
adjusted R-square value of .7080 provides some assurance this was the correct course of
action. When purchased care or combined purchased/military care observations were
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included, the explanation of variance fell by nearly half to .3559 and .3502, respectively.
As expected, bed days and age were statistically significant, as were the 25 illnesses
referenced earlier.
It is important to consider the results within the proper context. The list of
diseases originally requested from AF/SG was based on existing literature regarding
occupational illness. The results show that some diseases cost more or less, by a
statistically significant amount, than others. We acknowledge our results are based solely
on the disease set in our database. It is likely another data set of illnesses would produce
differing results. The take-away note here is that illnesses are unique and complex.
Attempting to model “illness” creates an overly parsimonious model with no true
estimation validity beyond ease of use, which is a poor measure of effectiveness.
Regression Diagnostics
Throughout the many iterations of the final regression model, we performed basic
diagnostics. We focused mainly on normality and heteroskedasticity. Since we
attempted to use three different dependent variables over all observations, military care
observations, and purchased care observations, we have a total of nine combinations to
check for normality and heteroskedasticity. Normality checks show if the dependent
variable comes from a normal distribution. In all cases, the goodness of fit test rejected
the null hypothesis that the data comes from a normal distribution. See the diagnostic
results in A9 through A17 for specific values. Our results were especially surprising for
the logarithmic transformation of costs. The histogram appears highly normalized for
each case, although the goodness of fit test still fails.
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Heteroskedasticity is non-constant variance, which is a violation of basic ordinary
least squares (OLS) assumptions. “Heteroskedasticity does not cause OLS coefficient
estimates to be biased. However, the variance (and, thus, standard errors) of the
coefficients tends to be underestimated, inflating t-scores and sometimes making
insignificant variables appear to be statistically significant (Wikipedia).” We checked for
heteroskedasticity by plotting the residuals against the predicted values for each version
of observation class and dependent variable. The resulting nine checks for
heteroskedasticity are also contained in the Appendix in A9 through A17. The logtransformed data did not appear heteroskedastic, but the others did.
We chose normalized occupational illness cost as our final dependent variable.
This dependent variable displayed heteroskedasticity. To overcome this, we used robust
standard errors. The coefficients do not change, but the standard errors are compensated
to account for the bias mentioned earlier. No variables dropped from our equation when
computing the robust standard errors. See Appendix A18 for the updated regression
estimates. The model specification remains unchanged and the robust standard errors are
provided to show we acknowledged and compensated for heteroskedasticity.
Now that the data has been analyzed, we continue our discussion of the results
and provide some recommendations for the decision maker. We also point out some
limitations in our research efforts and offer areas of further research.
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V. Discussion
Conclusion
Given the erratic nature of medical cost inflation, we initially theorized the DoD
cost factors would have understated the actual costs shown in our data. However, the
DoD no lost time factor seems to be overstated by 27% compared to our revised no lost
time factor. Also, the DoD hospitalization factor seems to be overstated by 20%
compared to our revised no lost time factor. It is possible the CPI-M index does not
apply accurately to military treatment costs as it does to purchased treatment costs. Also,
the lack of continuity within DoD hampers our understanding of how the original cost
factors were developed. It would greatly enhance our analysis if we knew the factors,
data, steps, theories, and logic used in the creation of those factors.
As we conclude this research endeavor, we must discuss limitations,
recommendations, and further research. Limitations include data collection problems,
understanding causes and courses of treatment for illnesses, and organizational
challenges. We recommend the use of our tools and factors developed within this
research effort. Finally, we provide several recommendations of future research
opportunities, both to add to the progress made here and to break into new areas of
concentration. First, consider the limitations we faced in this project.
Limitations
Any research project is sure to bring about a number of limitations. This project is
no exception. There are issues with data, timeframes, responsibility, oversight,
communication, privacy, and the inherent complex nature of occupational illnesses.
While each of these limitations causes considerable problems on its own, the culmination
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of limitations imposes a substantial challenge to adequately analyzing and modeling
illness costs in the Air Force.
Data Limitations
Data availability is extremely limited when researching occupational illness. The
civilian sector has mandated reporting of occupational injuries and illnesses to the
Department of Labor (DoL). The Bureau of Labor Statistics (BLS) then makes the
highly detailed data available via the internet. However, federal agencies are not required
to submit injury and illness data to the DoL. DoD civilian employee data is eventually
rolled up and reported to BLS, but the aggregated numbers do not differentiate between
illness and injury. Private sector data is presented in great detail, providing specific case
rates and occurrences for most injuries or illnesses. With a few clicks, one is able to
obtain days away from work, rates of illness incidence, fatalities, and much more for a
wide range of occupations in the U.S (bls.gov).
Illness data for Active Duty Air Force personnel is a little tougher to obtain.
The Defense Medical Epidemiology Database (DMED) provides case rates and
occurrences of any injury or illness associated with an ICD-9 code. However, there is no
way to confirm whether the injury or illness was a result of occupational exposure. To
overcome this problem, researchers have developed attributable factors to determine what
percent of a particular illness would likely be caused by occupational illness. However,
the incidence rates of the most costly illnesses (cancers, respiratory diseases, etc) are
extremely low. These categories of occupational illnesses usually manifest themselves
decades after exposure. Relatively speaking, the short twenty-year tenure of a full-career
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Air Force member does not provide the length of observation needed to capture a large
portion of most occupational illnesses, especially the most expensive ones.
In addition to the illness data challenges for Air Force military and civilian
employees, there are problems with obtaining the actual direct cost data for medical
expenses. Actual expenses are tied to actual cases. It is difficult to obtain costs for an
illness without accessing databases containing personal information on patients.
Thankfully for patients, but unfortunately for researchers, cost information is extremely
difficult to get. Institutional Review Board (IRB) protocols must be established to ensure
proper use and disposition of any medical information, even though the cost information
by itself is non-identifying.
Illness Timelines
Timeframes associated with occupational illness were touched on briefly, but
warrant further discussion. Occupational illness can be very small and simple, such as a
case of contact dermatitis caused by repeated exposure to a paint thinner solution.
Illnesses can also be very large and complex, such as mesothelioma caused by inhalation
of dust in an asbestos tile factory. Or, consider a case where a bartender is exposed to
second hand smoke for years and develops lung cancer. Determining the exact cause,
time, and place someone became ill is not easy. Many illnesses occur years, even
decades, after a person is exposed to a chemical, dust, fumes, et cetera. Illnesses can be a
result of many variables: exposure, genetic propensity for illness, health, diet, and
diligence in adhering to safe work practices, just to name a few. The expansive spectrum
of possible factors plays a major role in how long it takes a person to develop an
occupational illness.
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Organizational Challenges
Responsibility, oversight, and communication are related concerns or barriers to
effective occupational illness analysis. Short personnel tenures and even shorter budget
cycles do not promote long-term planning and intervention policies, particularly at the
unit level. Funding for occupational health initiatives usually comes from the Operations
and Maintenance (O&M) budget. Some costs (direct medical expenses) for occupational
illnesses come from Defense Health Program (DHP) money, a completely separate “pot
of money” within the DoD. Other direct medical costs are recouped from unit funds,
such as when civilian workers file a worker’s compensation claim as a result of
workplace illness or injury. Disability payments from more serious illnesses come from
the Department of Veteran Affairs (VA), yet another appropriation outside the DoD.
Commanders are duly concerned about the health and welfare of the workforce. Even so,
there are very few tangible benefits to investing resources in occupational health beyond
basic regulatory requirements.
Indirect costs and benefits may be more interesting to commanders as long as we
can properly quantify them. Productivity, morale, and turnover all impact the mission.
As noted in previous sections, turnover costs for civilians are absorbed at local levels.
Turnover/training costs for military personnel occur at differing levels of Air Force
appropriations or commands, such as the Personnel and O&M appropriations within the
Air Education and Training Command. Productivity and morale impact the mission, but
are generally unquantifiable as a service-wide application. Productivity for a fighter unit
is likely to differ significantly from productivity at a maintenance unit. Services
squadrons throughout the Air Force may have differing measures of productivity than a
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Contracting squadron. Associating costs to loss of productivity would have to occur at a
local level, negating the ability to roll up costs into a broader model. Finally, morale
would need to be measured through individual surveys over time. Evaluating morale and
assigning indirect costs is complex enough to be a research project of its own.
Illness Cost Profiles
Illnesses follow general profiles for course of treatment, depending on the type of
illness and patient demographics (McCoy, 2008). Differing courses of treatment lead to
unique cost profiles. For instance, a cancer patient may become hospitalized and receive
chemotherapy sessions at predetermined times during the hospitalization. Occupational
illness costs incurred due to cancer in this instance would be fairly consistent, on average,
across the hospitalization. Some bed days would result in low costs from observation and
basic sustenance. Other days would result in much higher costs from the chemotherapy.
Trauma patients normally have high initial costs from surgery or emergency care.
Follow-on bed days for observation and recuperation may result in fewer costs per bed
day.
Illness cost profiles also change depending on when the illness is discovered and
treated. The later the illness is discovered, the more costly the intervention becomes
(Ibid). For this reason, it may not be realistic to model each illness specifically. Based
on the available data, cancer is generally more expensive per bed day than tinnitus.
However, there are cases where tinnitus is more expensive per bed day, likely due to the
severity and timeframe of onset to treatment. Yet, total costs of cancer may be higher
based on the length of treatment.
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Courses of treatment for similar diseases may differ, based on the protocol of the
treatment facility, access to equipment and skilled personnel, and differing costs of
medical care across the country. In fact, the cost of health care can drastically change the
interpretation of medical cost data. Dr. J. Paul Leigh excluded two high-cost markets;
specifically, he excluded California and New York (Leigh, 1992). Including these much
higher-priced markets may skew the results and can certainly affect a cost per illness or
cost per bed day factor. Our data set did not indicate the geographic location of costs
incurred. Some graphic examples of how costs may be incurred for various diseases
across a timeframe are shown in Figure 12 below. The data used is arbitrary and is only
for the purpose of demonstrating how illness profiles may affect cost (McCoy, 2008). As
we discussed earlier, costs may occur at different times during a hospitalization
depending on the injury/illness, course of treatment, and severity of injury/illness.

Figure 12. Injury/Illness Cost Profile Examples.
$30,000
C
o
s
t

$25,000

P
e
r

$15,000

D
a
y

$5,000

$20,000
Cancer (Early Intervention)
Cancer (Late Intervention)

$10,000

Severe Traumatic Injury

$0
0

2

4

6

8

Bed Days

75

10

Note in the above figure, severe traumatic injury costs per day are very high, but
gradually get lower as the patient may stabilize and move into recovery/observation.
Cancer costs may follow an oscillating wave profile, with higher costs incurred on
chemotherapy treatment days and recovery/observation on other days. The onset, type,
and severity of the cancer may drastically alter the peaks of the costs, again shown in
Figure 12.
Recommendations
The author makes several recommendations as part of this research effort. Based
on the aforementioned results from the cost comparison tool and the regression results,
75th AMDS personnel should implement the new tool to enhance the effectiveness of
their occupational health project comparisons. The engineers should not limit the use of
the cost comparison tool to industrial hygiene visits. We recommend the tool be used to
analyze any significant capital outlay, or when determining which course of action may
be financially better over various timeframes and costs. We also recommend avoiding
manual data entry into spreadsheets whenever possible. Formulas provide transparency
and validity to spreadsheets by allowing analysts to see exactly how the calculations are
being made. Notes/comments should also be used to provide more continuity.
Additional recommendations involve the data collection, reporting, and analysis
of occupational illness of active duty Air Force members. Data repositories should be
integrated to allow easier comparison of direct medical costs with occupational illness
occurrence. Services should also seek to capture occupational illness-related disability
payments made by other agencies, such as the VA. Although the costs do not impact
service budgets, per se, the understanding of the magnitude of costs may influence
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decision makers when evaluating potential occupational health expenditures. Ideally,
analysis at higher federal budgetary levels may result in allowing cross-appropriation
funding for occupational health projects, with the goal of spending fewer dollars now to
prevent larger costs in the future.
We recommend the Department of Defense adopt our updated cost factors for
illnesses resulting in no lost time. We recognize the factors are based solely on Air Force
data. However, the fact that the factors have not been updated in 20 years is cause for
concern, especially if planners are using this information to allot taxpayer dollars for
medical expenses.
Further Research
Opportunities for further research include quantifying an indirect cost, such as
employee turnover. We encountered significant challenges linking employee discharge
with occupational illness. Modeling one component of indirect costs would greatly
improve our understanding of the magnitude of total illness costs. Better communication
and buy-in with organizations in charge of such data may improve the likelihood of
future research in this area.
Other research efforts should be directed at comparing direct medical costs across
services. The DoD cost factors may have been built upon data from all services.
However, lack of information from the DoD prevents us from understanding the
methodology behind the cost factors. Accurately planning direct medical costs at DoD
level requires access to direct medical costs from all services, regardless of who takes on
the research project to update the factors.
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Occupational illness is a challenging subject to research. However, the cost
savings implications of finding a better way of business provide excellent incentive for
further study. To start, successful research requires organizational support and access to
data. It also requires an understanding of the importance of occupational illness analysis
and mitigation beyond dollars and cents. We applaud those individuals we met during
this research effort who, on a daily basis, attempt to understand the problems and craft
solutions for occupational illness issues.
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Appendix
A1. List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors.

Illness
Malignant neoplasm of nasopharynx
Malignant neoplasm of liver/bile ducts
Malignant neoplasm of nasal cavities
Malignant neoplasm of larynx
Malignant neoplasm of trachea/bronchus/lung
Malignant melanoma of skin
Malignant neoplasm of bladder
Malignant neoplasm of kidney
Lymphoid leukemia
Myeloid leukemia
Monocytic leukemia
Other specified leukemia
Leukemia of unspecified cell type
Toxic encephalitis
Other cerebral degenerations
Parkinson's disease
Other specified hemiplegia and hemiparesis
Hereditary/idiopathic peripheral neuropathy
Polyneuropathy due to other toxic agents
Toxic myopathy
Hearing Loss Due to Noise
Tinnitus
Tinnitus, no other symptoms
Subjective Tinnitus
Objective Tinnitus
Contact Dermititis and other eczema
Bachache, no other symptoms
Carpal Tunnel Syndrome
Essential hypertension
Hypertensive heart disease
Hypertensive renal disease
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ICD-9
147
155
160
161
162
172
188
189
204
205
206
207
208
323.7
331
332
349.82
356
357.7
359.4
388.12
388.3
388.30
388.31
388.32
692
724.5
354.0
401
402
403

Mean Attributable
Factor
36.0%
0.8%
39.5%
10.5%
9.7%
3.8%
11.0%
1.2%
1.8%
1.8%
1.8%
1.8%
1.8%
2.0%
2.0%
2.0%
2.0%
2.0%
2.0%
2.0%
100%
100%
100%
100%
100%
100%
100%
100%
7.5%
7.5%
7.5%

A1 (Cont.). List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors.

Illness
Hypertensive heart and renal disease
Acute myocardial infarction
Acute/subacute ischemic heart disease
Old myocardial infarction
Angina pectoris
Other forms of chronic ischemic heart disease
Subarachnoid hemorrhage
Intracerebral hemorrhage
Other and unspecified intracranial hemorrhage
Occlusion and stenosis of precerebral arteries
Occlusion of cerebral arteries
Transient cerebral ischemia
Acute, but ill-defined, cerebrovascular disease
Other and ill-defined cerebrovascular disease
Late effects of cerebrovascular disease
Atherosclerosis
Bronchitis, not specified as acute or chronic
Chronic bronchitis
Emphysema
Asthma
Bronchiectasis
Extrinsic allergic alveolitis
Chronic airway obstruction, not elsewhere classified
Coal workers' pneumoconiosis
Asbestosis
Pneumoconiosis due to other silica or silicates
Pneumoconiosis due to inhalation of other dust
Pneumoconiosis due to other inorganic dust
Pneumoconiosis, unspecified
Respiratory conditions due to chemical fumes and va
Pulmonary Tuberculosis
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ICD-9

Mean Attributable
Factor

404
410
411
412
413
414
430
431
432
433
434
435
436
437
438
440
490
491
492
493
494
495
496
500
501
502
503
504
505
506
011

7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
15%
15%
15%
16%
15%
15%
15%
100%
100%
100%
100%
100%
100%
100%
5.5%

A1 (Cont.). List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors.

Illness

ICD-9

Mean Attributable
Factor

Mesothelioma
Chronic hepatitis
Cirrhosis of liver without mention of alcohol
Unspecified chronic liver disease
Acute glomerulonephritis
Nephrotic syndrome
chronic glomerulonephritis
Nephritis and nephropathy, unspecified
Acute renal failure
Chronic renal failure
Renal failure, unspecified
Renal sclerosis, unspecified

NA
571.4
571.5
571.9
580
581
582
583
584
585
586
587

100%
0.8%
0.8%
0.8%
11.4%
11.4%
11.4%
11.4%
11.4%
11.4%
11.4%
11.4%
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A2. Regression Matrix of Hospitalization Cost Factor Model Variations.

Illnesses
All
Exclude High Frequency
Exclude Cancer
Exclude Respiratory Disease
Exclude Circulatory Disease
Exclude Nervous System Disease
Exclude Other Illnesses
Include Only High Frequency
Include Only Cancer
Include Only Respiratory Disease
Include Only Circulatory Disease
Include Only Nervouse System Disease
Include Only Other Illnesses

All Observations

Military Care

Purchased Care

Bed Day Coefficient Adjusted R-Square
$
1,005.55
0.214
$
857.43
0.127
$
978.82
0.208
$
1,005.25
0.210
$
1,268.72
0.421
$
1,001.83
0.212
$
990.07
0.210
$
993.93
0.290
$
1,241.48
0.263
$
1,011.85
0.282
$
705.00
0.082
$
1,667.99
0.664
$
1,666.72
0.373

Bed Day Coefficient Adjusted R-Square
$
1,912.28
0.568
$
2,063.84
0.460
$
1,821.85
0.550
$
1,912.28
0.568
$
1,759.86
0.629
$
1,907.61
0.567
$
1,915.60
0.579
$
1,525.80
0.666
$
2,443.23
0.675
$
875.59
0.290
$
3,177.06
0.568
$
2,275.78
0.681
$
1,842.52
0.393

Bed Day Coefficient Adjusted R-Square
$
614.48
0.096
$
518.28
0.057
$
640.78
0.103
$
587.92
0.089
$
850.12
0.265
$
610.07
0.095
$
603.70
0.093
$
549.21
0.085
$
314.16
0.028
$
1,268.79
0.306
$
477.92
0.046
$
1,652.27
0.686
$
1,512.38
0.474
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A3. Scatterplot of All Hospitalizations: Disease Category and Bed Days
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A4. Scatterplot of Military Care Observations: Disease Category and Illness Cost
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A5. Scatterplot of Military Care Observations: Disease Category and Bed Days
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A6. Scatterplot of Purchased Care Observations: Disease Category/Illness Cost
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A7. Scatterplot of Purchased Care Observations: Disease Category and Bed Days
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A8. Final DoD Total Cost Factor Regression Results, Military Care.

Variable
Intercept
Occ Illness Bed Days
Age (Continuous)
ACT LYM LEUK W/O RMSION
ACUTE NEPHRITIS NEC
ACUTE RENAL FAILURE NOS
AMI ANTEROLATERAL, INIT
AMI INFERIOR WALL, INIT
ANEURYSM, HEART (WALL)
BACKACHE NOS
BRONCHITIS NOS
CARPAL TUNNEL SYNDROME 3
COR ATH ARTRY BYPAS GRFT
CRN ATH NONATLG BLG GRFT
CRNRY ATHRSCL NATVE VSSL
DERMATITIS NEC
EMPHYSEMATOUS BLEB
INTRACRANIAL HEMORR NOS
MAL NEO ACCESS SINUS NEC
MAL NEO ETHMOIDAL SINUS
MAL NEO MAXILLARY SINUS
MAL NEO UPPER LOBE LUNG
NONRUPT CEREBRAL ANEURYM
PULMON TB NOS-MICRO DX
SOLVENT DERMATITIS
SUBARACHNOID HEMORRHAGE 2
SUBENDO INFARCT, INITIAL
SUBENDO INFARCT, UNSPEC

Estimate Standard Error t-statistic Probability>t
90.02
113.76
0.79
0.429
1781.23
40.89
43.57
0.000
8.40
2.87
2.93
0.003
822.11
290.36
2.83
0.005
5896.43
813.96
7.24
0.000
306.73
128.78
2.38
0.017
3199.68
575.33
5.56
0.000
690.28
200.90
3.44
0.001
3639.93
813.04
4.48
0.000
1616.57
232.15
6.96
0.000
-639.05
184.38
-3.47
0.001
2965.11
408.42
7.26
0.000
2598.04
1151.48
2.26
0.024
2664.81
1149.48
2.32
0.021
1197.85
97.95
12.23
0.000
-4878.95
1165.21
-4.19
0.000
2440.51
435.97
5.60
0.000
1144.95
436.78
2.62
0.009
11807.23
1186.30
9.95
0.000
-5746.27
1171.94
-4.90
0.000
13304.27
1154.85
11.52
0.000
2508.60
576.17
4.35
0.000
1066.29
333.48
3.20
0.001
-1781.28
669.02
-2.66
0.008
-3278.66
1172.40
-2.80
0.005
2073.46
335.04
6.19
0.000
654.57
135.90
4.82
0.000
3354.83
813.44
4.12
0.000
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A9. Total Inpatient Care Diagnostics, Normalized Cost
Normality
Mean
16435.34
Std Dev
32756.98
Std Err Mean
519.03
Upper 95% Mean
17452.95
Lower 95% Mean
15417.74
N
3983
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.309055
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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Heteroskedasticity
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A10. Total Inpatient Care Diagnostics, Log Normalized Cost
Normality
Mean
3.9461
Std Dev
0.45883
Std Err Mean
0.0072
Upper 95% Mean
3.9604108
Lower 95% Mean
3.9319033
N
3983
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.032059
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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5

6

Heteroskedasticity
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A11. Total Inpatient Care Diagnostics, Normalized Occupational Illness Cost
Normality
Mean
1267.08
Std Dev
2103.10
Std Err Mean
33.32
Upper 95% Mean
1332.41
Lower 95% Mean
1201.75
N
3983
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.273964
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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30000

40000
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A12. Military Inpatient Care Diagnostics, Normalized Cost
Normality
Mean
18795.48
Std Dev
31780.82
Std Err Mean
785.49
Upper 95% Mean
20336.15
Lower 95% Mean
17254.81
N
1637
Goodness-of-Fit Test
Shapiro-Wilk W Test
W
Prob<W
0.458134
0.0000
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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A13. Military Inpatient Care Diagnostics, Log Normalized Cost
Normality
Mean
4.0225
Std Dev
0.4280
Std Err Mean
0.0105
Upper 95% Mean
4.0432
Lower 95% Mean
4.0017
N
1637
Goodness-of-Fit Test
Kolmogorov's D
D
Prob>D
0.050201
<
0.0100
Note: Ho = The data is from the LogNormal distribution. Small p-values reject Ho.

3

4

5

Heteroskedasticity
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A14. Military Inpatient Care Diagnostics, Normalized Occupational Illness Cost
Normality
Mean
1502.42
Std Dev
2125.34
Std Err Mean
52.5298
Upper 95% Mean
1605.45
Lower 95% Mean
1399.39
N
1637
Goodness-of-Fit Test
Shapiro-Wilk W Test
W
Prob<W
0.557554
0.0000
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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20000

30000
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A15. Purchased Inpatient Care Diagnostics, Normalized Cost
Normality
Mean
14788.48
Std Dev
33329.08
Std Err Mean
688.11
Upper 95% Mean
16137.85
Lower 95% Mean
13439.11
N
2346
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.329765
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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A16. Purchased Inpatient Care Diagnostics, Log Normalized Cost
Normality
Mean
3.8928
Std Dev
0.4719
Std Err Mean
0.0097
Upper 95% Mean
3.911983
Lower 95% Mean
3.873768
N
2346
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.028913
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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5

Heteroskedasticity
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A17. Purchased Inpatient Care Diagnostics, Normalized Occupational Illness Cost
Normality
Mean
1102.86
Std Dev
2072.11
Std Err Mean
42.780
Upper 95% Mean
1186.75
Lower 95% Mean
1018.97
N
2346
Goodness-of-Fit Test
KSL Test
D
Prob>D
0.297847
<
0.0100
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho.
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A18. Parametric Estimates for Military Inpatient Care, Robust Standard Errors.
Variable

Estimate

Std Error

LR Chi2

P>Chi2

Intercept

90.021178

112.78004

0.6370015

0.4248

Age Continuous

8.398475

2.8431295

8.7026732

0.0032

ACT LYM LEUK W/O RMSION

822.11306

287.86959

8.135643

0.0043

ACUTE NEPHRITIS NEC

5896.4303

806.96926

52.538361

<.0001

ACUTE RENAL FAILURE NOS

306.72886

127.67603

5.7613743

0.0164

AMI ANTEROLATERAL, INIT

3199.6803

570.38698

31.16971

<.0001

AMI INFERIOR WALL, INIT

690.28367

199.17353

11.967502

0.0005

ANEURYSM, HEART (WALL)

3639.9258

806.05927

20.26563

<.0001

BACKACHE NOS

1616.568

230.1529

48.606181

<.0001

BRONCHITIS NOS

-639.0501

182.79691

12.176314

0.0005

CARPAL TUNNEL SYNDROME

2965.1116

404.90901

52.765385

<.0001

COR ATH ARTRY BYPAS GRFT

2598.0398

1141.5923

5.1711058

0.0230

CRN ATH NONATLG BLG GRFT

2664.8142

1139.6083

5.4588147

0.0195

CRNRY ATHRSCL NATVE VSSL

1197.8538

97.113428

145.4816

<.0001

DERMATITIS NEC

-4878.949

1155.1974

17.741269

<.0001

EMPHYSEMATOUS BLEB

2440.5126

432.22535

31.575227

<.0001

INTRACRANIAL HEMORR NOS

1144.9517

433.02879

6.9761387

0.0083

MAL NEO ACCESS SINUS NEC

11807.233

1176.1067

97.805741

<.0001

MAL NEO ETHMOIDAL SINUS

-5746.275

1161.872

24.279046

<.0001

MAL NEO MAXILLARY SINUS

13304.272

1144.9287

129.74799

<.0001

MAL NEO UPPER LOBE LUNG

2508.6021

571.22095

19.173855

<.0001

CEREBRAL ANEURYM1SM

2066.2866

330.61204

10.36894

0.0013

PULMON TB NOS-MICRO DX

-1781.275

663.2731

7.1965169

0.0073

SOLVENT DERMATITIS

-3278.658

1162.334

7.9373774

0.0048

SUBARACHNOID HEMRGE

2073.4588

332.16164

38.510001

<.0001

SUBENDO INFARCT, INITIAL

654.56833

134.73528

23.433393

<.0001

SUBENDO INFARCT, UNSPEC

3354.8306

806.45455

17.214558

<.0001

Occupational Illness Bed Days

1781.2291

40.533946

1275.4918

<.0001
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A19. No Lost Time Factor, Normality Check Using Shapiro – Wilk Test.

Shapiro-Wilk W test for normal data
Variable

Obs

W

V

z

Prob>z
Norm Occ Illness Cost 71872 0.13775 2.1e+04
0.00000
Ho: Data is from normal distribution.
Based on V coefficient, Ho is rejected.
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27.743

A20. No Lost Time Factor Heteroskedasticity/Breusch-Pagan Test.

Breusch-Pagan LM statistic: 5087832 Chi-sq( 1) P-value =

0

Heteroskedastic Robust Standard Error Results:
Number of obs = 71872
F( 1, 71870) =10740.95
Prob > F = 0.0000
R-squared = 0.8870
Root MSE = 3778.8

Variable

Factor Std. Err.

T-stat

P>|t

Norm Occ Illness Cost

235.59

2.27

103.64

0.000

Constant

-27.18

13.50

-2.01

100

0.044

95% Conf Int
231.13 240.04
-53.64

-.72
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